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Summary
The development of successful joint replacement prostheses and the 
widespread use of fracture fixation devices have revolutionised the practice of 
orthopaedic and trauma surgery over the last thirty years. The metal alloys used 
for such implants are chosen both for their mechanical strength and high degree of 
biocompatibility. However, over time, the processes of in vivo corrosion and 
w ear liberate metals from all o f the alloys in current use. Some metals are 
recognized carcinogens in the industrial environment and in recent years there 
have been grow ing num bers o f reports of m alignant tum ours associated with 
metal implants in patients. In relation to the millions of patients who have benefit- 
ted from such operations, these reports remain small in number but have raised 
concern over the possible effects of long term exposure to metal from implants.
Recent developments in cell culture techniques have made it possible 
to study, in vitro, cellular mechanisms associated with carcinogenesis and to apply 
these methods as screening tools. This study therefore investigated and compared 
the ability of the commonly used implant metals to induce neoplastic transforma­
tion and toxicity in fibroblasts in cell culture. E ight m etals, namely cobalt, 
chromium, nickel, iron, molybdenum, aluminium, vanadium and titanium, were 
tested both as soluble salts and as solid particles. Two cell lines were employed, 
CSH/IOT1/  ^ mouse fibroblasts and diploid human fibroblasts.
There were marked differences between the various metals in terms 
of both toxicity and transforming ability. In the mouse fibroblast assays, signif­
icant increases in transformation incidence were seen with cobalt, chromium, 
nickel and molybdenum, but not with iron, aluminium, vanadium or titanium. For 
most of the metals, transforming ability was directly related to toxicity though this 
correlation was not seen with molybdenum and vanadium. The physical form of 
the metal was important in that transformation occurred only with soluble prepara­
tions, possibly reflecting differences in cellular uptake. In the human cell assays, 
reliable controls could not be produced and metal transformation studies could not 
be pursued. However, cytotoxicity assays gave results similar to those seen in the 
mouse cells.
The mechanisms involved in the release, distribution and biological 
interaction of corrosion and wear products are complex and only partially ex­
plained. At the present level of understanding, it is not possible to quantify the 
risk, if  any, of malignant complications. The results of this study provide a way 
of grading the relative risks of orthopaedic implant metals in terms of toxicity and 
potential carcinogenicity. Of the three available alloys, stainless steel and cobalt- 
chromium contain significant amounts of those metals which caused toxicity and 
cell transformation, whereas none of the constituents of titanium alloy showed 
evidence o f transform ing ability. On this basis the safest alloy in current use 
would appear to be titanium alloy.
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CHAPTER ONE
THE CARCINOGENIC RISK OF IMPLANTED ORTHOPAEDIC METALS
1.1 The evolution of modern orthopaedic alloys.
1.1.1 Early developments.
The use of metal implants in surgical practice has its origins in the 
late eighteenth and early nineteenth centuries with the use of wire cerclage in the 
treatment of fractures and pseudarthroses. A number of metals were employed 
including brass, gold, silver and platinum, but the ever present problems of infec­
tion limited their widespread application. Nevertheless, even in those early days, 
some important observations were made. Bell (1804) noted the occurrence of 
galvanic corrosion of steel tipped silver pins in body fluids - a lesson which has 
been relearned many times in the years since. In the earliest biocompatibility 
experiments, Levert (1824) tested gold, silver, lead and platinum ligatures in dogs 
and found platinum to be the least irritating. The advent of Listerian antiseptic 
methods, which made possible the great advances in surgery of the late nineteenth 
century, also led to the more adventurous use of foreign implants, and it is proba­
bly no coincidence that Lister's own early reports included accounts o f wire fixa­
tion of fractures (Lister 1883).
The earliest plating system for the fixation o f fractures was de­
scribed in the German literature by Hansmann (1886) who used nickel plated sheet 
steel. The plate was bent at a right angle so that one end protruded through the 
skin, as did the screw heads, in order to facilitate removal. W hether this was 
further assisted by sepsis is not known! Innovations w ere also being made in 
Britain, notably by Lane (1893) who used steel screws to fix ununited fractures, 
and later developed the forerunner of the modern fracture plate, fashioned from
l
high carbon (stout) steel (Lane 1914). Although it enjoyed a degree of popularity, 
Lane's plate was inherently weak, partly because of the relative brittleness of the 
material, and partly from deficiencies in its mechanical design, and breakage was 
not uncommon. Sherman (1912) introduced a major improvement with a more 
robust design made from the recently available vanadium steel, though this in turn 
developed problems as the plate, while mechanically satisfactory, was liable to 
corrosion and loosening. Contributions were also made around this time by Hey- 
Groves (1913) and Lambotte (1913). They studied various methods o f fracture 
treatm ent and also investigated the m aterials used for internal fixation. Both 
found that magnesium plates corroded rapidly in the tissues and H ey-G roves 
suggested that nickel-plated steel produced the least reaction.
1.1.2 Stainless steel.
Progress had thus been made in overcoming infection and improving 
m echanical perform ance but it was clear that a more biologically  com patible 
material was required. In addition further development was stimulated by the 
need for better methods of treating fractures of the femoral neck. The earliest 
version o f stainless steel, containing 18% chrom ium  and 8% nickel, becam e 
available in the 1920's. It was used by Smith-Peterson for his femoral neck nail 
which so greatly improved the treatment of femoral neck fractures (Smith-Peter- 
son et al, 1931). A side plate was later added by Thornton (1937) to form the 
prototype of the now familiar proximal femoral fixation device. This "18-8" steel 
was far from being corrosion-free in vivo, as pointed out by later studies (Speed 
1935, Harris 1938). The incorporation of molybdenum 2-4% was found to great­
ly improve its corrosion resistance. Although this alloy was originally patented in 
1926, it was many years before "18-8-SMo" steel, as it was called, became the 
steel o f choice for im plantation. In the years since then, m odifications in its
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composition and fabrication have been made to produce the 316L stainless steel in 
use today.
1.1.3 Cobalt-chromium alloy.
Cobalt based alloys had been investigated by Zierold as early  as 
1924 in the form of Stellite (58% cobalt, 35% chromium, 4% tungsten) which 
was found to excite very little tissue reaction. Vitallium, a close relation o f Stel­
lite, which in addition contained molybdenum, became available around 1930. It 
found early use as a dental alloy, but only came to orthopaedic attention later with 
the studies of Venable who found that it was highly resistant to corrosion and 
produced virtually no bone or tissue reaction (Venable et al 1937). After that time 
it came progressively more into use as an alternative to stainless steel.
Smith-Peterson again made use o f the new material. Despite the 
im provem ents in the fixation o f fem oral neck fractures failure and secondary 
arthritis remained a problem. This naturally led to interest in methods of arthro­
plasty and Smith-Peterson developed the concept of cup arthroplasty in an attempt 
to resurface the femoral head. After experimenting with glass and celluloid, he 
found that V itallium  had the necessary m echanical and biological properties 
(Sm ith-Peterson, 1948). His own results were reasonably good but w ere not 
repeated by other surgeons. Better methods of joint replacement were pursued.
The first total hip replacements were performed by Wiles as early as 
1938 on young patients with Still's disease, using stainless steel for both compo­
nents (W iles, 1957). The prosthetic acetabulum  was fixed to the pelv is with 
screws, and the new fem oral head was on the end o f a bolt inserted along the 
femoral neck and fixed to the femoral shaft with a plate and screws. His results 
were not encouraging however, and further developments were directed towards 
replacem ent o f the fem oral head alone. Thom pson (1954) and M oore (1959)
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developed their metal prostheses with more success. Both were made from co- 
balt-chromium-molybdenum alloy and had stems for insertion into the femoral 
shaft. With the desired mechanical properties and tissue acceptability they came 
into regular use and remain so today along with a number of similar devices.
1.1.4 Titanium alloy.
After the second world war, the commercial production of titanium 
increased markedly. It was well known for its high degree of corrosion resistance 
and the metal soon came to medical attention. Early studies by Leventhal (1951) 
and Beder et al (1956) indicated a high degree of tissue tolerance to the metal and 
by the late 1950's, titanium implants were being marketed in the United Kingdom. 
Initially, commercially pure titanium was used but was found to lack the desired 
fatigue resistance in load-bearing com ponents. In the early 1970 's, titanium - 
aluminium-vanadium alloy (Ti6A14V) was introduced, having superior mechanical 
qualities but similar tissue acceptability to the pure metal.
The com positions of the three alloy systems used in orthopaedic 
implants are listed in Table 1.
1.1.5 Recent developments.
Further developments in implant surgery, particularly in the field of 
jo in t replacement have been aimed towards specific surgical and biomechanical 
problems. Femoral head replacements caused long term problems with acetabular 
erosion and were ineffective in treating established arthritis. The need for a satis­
factory total hip replacement was clear. McKee (1951, 1966, 1970) and Chamley 
(1960, 1964, 1972) developed their prostheses concurrently but along different 
lines. McKee chose Vitallium for both components and produced a reasonably
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successful prosthesis. Charnley used stainless steel but made his major advances 
in the use of polymethylmethacrylate cement for anchorage of the components, and 
the development of the "low friction" joint using polyethylene for the acetabular 
component. The great success of Charnley's design led to the introduction of 
countless variations of the original using all the standard orthopaedic alloys.
M echanical loosening rem ains the major, and perhaps inevitable 
cause o f joint replacement failure, particularly in younger more active patients. 
Revision surgery is often difficult due to loss of bone stock and the presence of 
retained cement. Ring (1974, 1983) had persisted with uncemented methods, 
relying on an interference fit for the stability of his components. Initially using an 
all-metal cobalt-chromium prosthesis he later changed to the now standard metal- 
plastic articulation. His results prompted many surgeons to adopt uncemented 
methods in an attempt to avoid the problems of revision surgery and in recent 
years increasing numbers of uncemented joint replacements have been inserted 
into relatively young patients.
The most recent development in the field of implant metals has been 
the introduction of porous coated implants, using either cobalt-chromium alloy 
(Welsh et al 1971) or titanium (Galante et al 1971). The aim is to encourage bone 
and soft tissue growth into the surface pores of such com ponents to achieve 
"biological fixation" o f the implant. Numerous devices are now available with 
certain parts of their surfaces covered with porous layers made from sintered 
cobalt alloy spheres, sintered pure titanium spheres or titanium fibres. The long 
term advantages of these devices remains to be proven however.
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Table 1. Principal constituents of orthopaedic implant alloys.
Stainless Steel
Iron 59-70%
Chromium 17-20%
Nickel 10-17%
Molybdenum 2-4%
Cobalt-chromium alloy (Vitallium)
Cobalt 57-65%
Chromium 27-30%
Molybdenum 5-7%
Titanium alloy (Ti6A14V)
Titanium 88-92%
Aluminium 5-6%
Vanadium 3-4%
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1.2 Corrosion and wear of modern implant alloys.
Until the last thirty years or so, the gradual refinements in alloy composi­
tion and design discussed in the previous section were made largely on the basis 
of rather crude assessment methods. Implanted metals, whether in animal models 
or in human patients, were inspected for gross signs of corrosion or mechanical 
failure. Implant sites were examined at surgery and radiographically for evidence 
of bone or soft tissue reaction, occasionally with the addition of histological study. 
In recent years improved analytical techniques have shown that modern implant 
alloys, though highly resistant to corrosion in the industrial environment or under 
simple test conditions, can still release appreciable amounts of corrosion products 
in vivo. This was clearly demonstrated by Ferguson et al (1960, 1962). In a 
series of experiments on rabbits, using a number of metals and alloys, they found 
increased levels of metal in the tissues surrounding static implants and in other 
organs distant from the site of implantation.
1.2.1 Rates of corrosion.
A full account o f the mechanism s o f in vivo  corrosion o f metal 
im plants is beyond the scope o f this work and may be found in o ther sources 
(W illiam s and Roaf 1973, Black 1988a). All metals are liab le to develop a 
corrosion current in an aggressive electrolyte solution such as the interstitial fluid. 
This is known as uniform attack. During manufacture the corrosion resistance of 
metal implants is increased by acid treatment. This process, known as passiva­
tion, creates a surface layer of metal oxides and hydroxides which acts as an 
insulator. Steinemann (1980) has estimated the corrosion current to be around 
10 2 to 10~3 juA/cm2 for a cobalt-chrom ium  im plant with an in tact passivating 
layer. This would be equ ivalen t to a re lease  o f approx im ate ly  30-60  fig 
m etal/day (11-22 m g/year) for the average fem oral com ponent o f a total hip
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replacement (Black 1988b). This calculation was based on a hypothetical femoral 
component with a total surface area of 200 cm'2.
Other factors however may increase this basic rate. In vitro experi­
ments indicate that the presence of serum proteins shifts the equilibrium towards 
more metal release. In the clinical situation, a well fixed cement mantle may 
afford some protection by reducing the exposed surface area though this is not 
entirely certain. Conversely, the use of uncemented components exposes a greater 
surface area o f metal to the tissue fluids, and with the introduction o f porous 
coated implants this increased surface area effect may be further enhanced.
O ther form s of corrosion may add to or accelerate corrosion in 
metal implants. Galvanic corrosion occurs when two metals of differing electro­
chemical potential lie in contact in the electrolyte solution. The baser of the two 
metals corrodes preferentially while the other is protected. In clinical practice this 
situation only occurs with combinations of stainless steel and other alloys and is 
therefore avoided. Cobalt-chromium and titanium alloy have similar electrochem­
ical potentials and can usually be combined without difficulty.
Crevice corrosion, as the name suggests, occurs in cracks or recess­
es such as between screw heads and plates. It appears to be related to oxygen 
depletion within the crevice relative to the surface of the device. It is probably of 
most concern for its possible weakening effect in fixation devices though it has 
been suggested that crevice corrosion may occur in the gap between metal and 
cement in joint replacements.
In jo in t replacements the components are not static but articulate 
with each other causing wear or fretting of the surface of the components. In 
metal/plastic articulations in normal conditions the wear on the metal side is not 
likely to be great, though there may be damage to the passivating layer. This 
process may be increased further by the presence o f bone or cem ent debris
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scratching the articulating surfaces and causing "third-body" wear. Mechanical 
loosening of the prosthesis may also increase relative movement of the compo­
nents and consequently increase wear and metal release.
1.2.2 Metal release from all-nietal joints.
Heavy tissue staining with metal wear debris or "metallosis" was a 
common finding with metal-on-metal articulations. The use of all-metal jo in t 
replacements has now been abandoned in favour of the mechanically superior 
metal-on-plastic articulation. Coleman, Harrington and Scales (1973), in one of 
the earliest studies, showed the importance of wear in all-metal hip joints. All 
nine patients with metal-on-metal joints had significantly raised blood and urine 
metal concentrations when compared with three patients with metal-on-plastic hips 
who had no measurable increases in blood or urine. Vernon-Roberts and Freeman 
(1977) examined the tissues adjacent to hip replacements at revision procedures. 
They found great differences in the levels of cobalt, chromium and nickel between 
all-metal CoCr joints, which gave very high levels, and CoCr-plastic hips which 
had lower levels. In addition, they found intermediate levels next to CoCr hemi­
arthroplasties articulating with bone. Smethurst and Waterhouse (1978) examined 
all-m etal hips requiring revision and recorded very high levels o f cobalt and 
chrom ium  in the tissues adjacent to the loose prostheses. Dobbs and M inski 
(1980) in a post mortem study also found high local levels but reported levels in 
distant organs including lungs, liver and spleen to be up to 50 times the expected 
values.
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1.2.3 M etal release from metal-on-plastic joints: stainless steel and cobalt- 
chromium alloy.
More recent work has shown that measurable amounts of metal can 
be released by metal-on-plastic joints. Studies carried out on patients some 
years after joint replacement indicate local and systemic increases in metal concen­
trations in the presence of prosthetic loosening. Pazzaglia et al (1983) found 
increased blood and urine levels of chromium, nickel and manganese in patients 
with stainless steel-poly ethylene total hip replacements. A further study showed 
increases in plasm a and urine of cobalt and chrom ium  in patients w ith CoCr- 
polyethylene joints (Pazzaglia et al 1986). Most of the patients in these studies 
had radiological evidence of loosening of the femoral component. Patients under­
going revision surgery for aseptic loosening of CoCr-polyethylene hip replace­
ments also have increased concentrations of cobalt, chromium and nickel in the 
tissues surrounding the prosthesis (Michel et al 1984, Lewis et al 1991). Most 
recently, a post mortem study of a patient with a loose Charnley stainless steel- 
polyethylene hip replacement found evidence of dissemination of metallic debris 
to distant sites including lymph nodes, liver and spleen (Langkamer et al 1992).
Fewer investigations have been carried out on patients with well- 
fixed joint replacements and results are somewhat conflicting. Some studies on 
patients before and after CoCr-polyethylene total hip replacement revealed tran­
sient increases in serum chromium and nickel concentrations in the post-operative 
months (Black et al 1983, Bartolozzi and Black 1985). Others show post-opera­
tive increases in serum cobalt but not in chromium or nickel (Michel et al 1991). 
Linden et al (1985) found no evidence of increased blood nickel levels in 12 out 
of 13 patients with well-fixed stainless steel-polyethylene hip replacements nine to 
fifteen years after implantation. The one patient with hypernickelaemia also had 
renal insufficiency which may have been a contributory factor.
10
1.2.4 Wear of titanium alloy implants.
Of the materials currently in use, titanium and its alloys are the most 
recent on the scene with reputedly the greatest degree of corrosion resistance but, 
paradoxically, growing evidence of the greatest susceptibility to wear. Metallosis, 
formerly a common feature of all-metal joint replacements, has not been a prob­
lem with stainless steel or cobalt-chrom ium  articulating with polyethylene. 
However, in recent years a number of papers have reported this finding in titani­
um alloy-poly ethylene joints. Agins et al (1988) noted dark staining of the tissues 
around titanium alloy implants at revision procedures. On measuring the content 
o f titanium , alum inium  and vanadium in the tissues adjacent to loose fem oral 
components they found alarmingly high levels in many cases. Sim ilar tissue 
staining at revision procedures was described by Witt and Swann (1991). Black et 
al (1990) reported a case of metallosis in a well fixed Ti6A14V-polyethylene hip 
replacement in which severe wear of the femoral head appeared to be the cause. 
These reports have prompted suggestions for alterations to the present titanium 
alloy in order to improve its wear resistance (Scales 1991).
The problem is illustrated in figures 1.1 and 1.2 which show sec­
tions of pseudocapsule removed at revision of a titanium alloy-polyethylene hip 
replacem ent. Revision was carried out for aseptic loosening three years after 
implantation. At operation the femoral component was loose within the femoral 
canal and the surrounding tissues were darkly stained with wear debris.
1.2.5 Metal release from uncemented and porous coated implants.
Studies o f patients with uncem ented or porous coated prostheses 
have yet to show clearly whether such devices liberate proportionately greater 
quantities of metal. Dorr et al (1990), in an ambitious study, examined the tissues 
o f 46 patients with CoCr-polyethylene and Ti6A14V-polyethylene hip replace-
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Fig. 1.1 Pseudocapsule removed at revision o f  Ti6A14V femoral  
component .  Low power view showing blackening o f  tissue with metal  wear 
debris. (H&E, x25).
. J  *
mam
iS
Fig. 1.2 High power view of  less densely blackened area shows tissue 
macrophages and multinucleate giant cells containing particulate debris.  
(H&E, x400).
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ments. There were cemented and uncemented varieties o f each and they further 
subdivided them into loose and well-fixed prostheses. The final numbers in each 
subgroup were consequently small but there appeared to be a slightly increased 
level o f metal ion release in the uncemented joints. Overall, the highest levels 
were associated with loose implants of both cemented and uncemented types.
Braun et al (1986) measured urinary cobalt and chromium in patients 
with a CoCr porous im plant estim ated to increase the surface area by about a 
factor o f three. They found significant increases in chrom ium  but not cobalt 
compared with controls. Output of both metals was far below levels found in 
patients with McKee-Farrar all-metal joints included in the same study. Converse­
ly, Jorgensen et al (1983) compared patients with porous and non-porous CoCr 
hem i-arthroplasties and found a 69% increase in urinary cobalt in the porous 
group, though the numbers included were small and there was marked overlap 
between the groups. Sunderman et al (1989) examined a group of patients with 
porous-coated knee and hip replacements and found small but significant increases 
in serum and urine cobalt in those with knee replacements but not those with hip 
replacements.
At present there is therefore no substantive evidence that the in­
creased surface area o f porous-coated im plants causes significant increases in 
metal release. However, concern has been expressed that loosening of sintered 
coatings may lead to accelerated fretting corrosion in some circumstances (Buc- 
hert et al 1986, Hamblen and Paul 1988).
Previous studies o f metal release from im plants have therefore 
produced varying and sometimes conflicting results. This reflects the many diffi­
culties inherent in such work which include variations in im plant designs and 
surgical techniques, differences in tissue selection and sampling methods, and
13
different methods and standards of analysis. As a result the actual values record­
ed from patients and controls may vary greatly from one study to another. Never­
theless the weight of evidence indicates that all joint replacements liberate some of 
their constituent metals and that the amounts are greatly increased by loosening 
and wear.
1.3 The adverse effects of implanted metals.
The general toxicity of many metals, including some of those used in 
orthopaedic implants, is well established and there is an extensive literature on the 
subject (Williams 1981). The overall effect of any implant on the recipient is the 
result of the balance between the properties of the implant materials and the host 
response to those materials. These responses may result in local effects around 
the implant or systemic effects elsewhere in the body.
1.3.1 Local effects.
All solid implants provoke a non-specific local reaction in the form 
of the normal healing response followed by a foreign body response. The latter is 
seen as an attempt to either break down or isolate the foreign material and results 
in the implant being enveloped in a fibrous capsule. This may be of little conse­
quence in the case of static devices such as fracture plates or may be the begin­
nings of mechanical loosening in the mobile components of a joint replacement.
With the release of corrosion and wear products o ther tissue re ­
sponses are provoked. Williams and Meachim (1974) studied the tissue changes 
around nonarticulating stainless steel implants and demonstrated varying degrees 
of inflammatory cell infiltration associated with areas of corrosion. In most cases 
this was not clinically significant but in some was severe enough to cause symp­
toms requiring rem oval o f the device. Rae (1981) investigated the effects o f
14
various metals at low concentrations on cultured human fibroblasts using enzyme 
release and morphological changes as indicators of toxicity. Toxic effects were 
observed with cobalt and nickel but, based on estimates of metal release from 
other experiments, he suggested that in clinical conditions toxic levels o f metal 
were only likely with metal-on-metal cobalt-chromium hip replacements where 
excessive wear could produce high levels of cobalt. The evidence for direct cellu­
lar toxicity from metal in clinical circum stances is less clear cut. Cases o f 
extensive aseptic tissue necrosis in association with high levels o f metallic wear 
debris from cobalt-chromium joint replacements are well documented (Evans et al 
1974, Jones et al 1975). However, the histological findings suggested that the 
severe tissue damage resulted from hypersensitivity to the metals involved rather 
than a direct toxic effect.
More recently metallic wear debris from titanium alloy hip replace­
ments has been shown to produce severe granulom atous reactions leading to 
osteolysis and failure of the prostheses (Lombardi et al 1989). This reaction is not 
unique to metallic debris and is well known in association with polyethylene wear 
particles.
1.3.2 Systemic effects.
Many metals play essential roles in norm al m etabolic processes. 
Indeed, all o f the m ajor constituents o f im plant alloys with the exceptions o f 
aluminium and titanium have been identified as essential trace elements (Mertz 
1981). Chromium is required for the normal action of insulin in sugar metabo­
lism and clinical effects from chromium deficiency have been described in pa­
tients on parenteral nutrition. Cobalt is an essential constituent of vitamin B12 
and was formerly used in the treatment of anaemia. However, all trace elements 
can cause toxicity when the normal range of exposure is exceeded. Defects in
15
iron metabolism lead to haemochromatosis. The use of cobalt as a stabiliser in 
beer led to an outbreak of cardiomyopathy in heavy drinkers (Alexander 1969). 
M ost recently aluminium has been implicated in the aetiology of A lzheim er's 
disease (Perl and Brody 1980). The effect of corrosion products on metabolic 
processes is not known. However, trace element analysis studies of periprosthetic 
tissues have shown changes, not only in the tissue levels of those metals derived 
from implants but also in the levels of other metals, suggesting some alteration in 
metabolic mechanisms (Michel et al 1984).
Metals by themselves do not cause allergies as such but, in combina­
tion with proteins, they are capable of provoking an immune response. M etal 
sensitivity is well recognised with items of jewellery and there is evidence that it 
occurs in patients with implants. Cramers and Lucht (1977) described dermatitis 
associated with stainless steel fracture plates in patients with positive skin tests for 
chromium and nickel. More recently it has been suggested that sensitivity to tita­
nium may occur in some cases (Lalor et al 1991). The number o f patients with 
overt metal sensitivity related to implants appears to be relatively small but studies 
using more sensitive cell migration inhibition tests have demonstrated sensitivity 
in over 50% of patients with implants (Merritt and Brown 1985).
The extent to which metal implants exert adverse or unwanted ef­
fects depends on a great number of factors. In the great majority of patients they 
do not appear to cause clinically significant problems but it is clear from this brief 
review that such effects may occur in a number of ways. One other possible risk 
of metal implantation remains - the risk of malignant change.
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1.4 Metal-associated cancer.
Of all the possible biological effects of implanted metals, by far the 
most worrying is the risk of malignant change. A number of metals have received 
attention as potential carcinogens in the industrial environment and many have 
been investigated experimentally. The general field of metal carcinogenesis is 
reviewed extensively by Sunderman (1978,1984). Our knowledge o f metal car­
cinogenesis comes from a number of sources. These include epidemiological 
studies of environmental and industrial exposure, animal experiments, cell culture 
studies, and, of particular interest in orthopaedics, reports of malignant tumours in 
patients with metal implants.
1.4.1 Epidemiological studies of industrial exposure.
Of the metals commonly used in orthopaedics, chromium and nickel 
are strongly implicated by epidemiological studies. Workers exposed to chromate 
dust have increased rates of lung cancer mortality (Alderson et al 1981, Satoh et 
al 1981, Hayes et al 1979), and nickel refinery workers have increased mortality 
from lung or nasal sinus malignancies (Chovil et al 1981, Magnus et al 1982, 
Enterline and Marsh 1980). The site of these tumours in the respiratory tract is 
clearly related to the route of exposure i.e. inhalation. How this relates to metal 
exposure from orthopaedic implants is less clear. Such studies have also shown 
that, as with other human carcinogens, there is usually a long latent period be­
tween exposure to the metals and tumour manifestation.
1.4.2 Carcinogenesis bioassays in animals.
A large number of reports have now established the ability o f var­
ious metals to produce malignant tumours in experimental animals. These metals 
include nickel, chromium, cobalt and iron, in addition to a number of other metals
17
not normally used for orthopaedic purposes. These studies are too numerous to 
mention in detail, but are comprehensively reviewed by Sunderman (1978,1984) 
and Pedley et al (1981). Some are o f particular interest as they studied orthop­
aedic alloys.
Oppenheimer et al (1956), implanted discs of metal foil subcutane- 
ously in rats. A number of alloys were studied including stainless steel and vital- 
lium, both o f which were associated with tumour formation. Heath et al (1971) 
and later Swanson et al (1973), reported on the occurrence of sarcomata in 22 out 
of 80 rats injected with wear particles from cobalt-chromium alloy joint prosthe- 
ses. The particles were generated in laboratory simulators and suspended in horse 
serum before injection. The presence o f the horse serum may have had some 
influence on the outcome. Conversely, Meachim et al (1982) implanted cobalt- 
chromium particles in the dry state and in two size ranges into a large number of 
rats and guinea pigs and found no evidence of sarcogenicity. Investigating the 
effects of solid implants, Gaechter et al (1977) studied several orthopaedic alloys 
including stainless steel, wrought and cast cobalt-chromium alloy, pure titanium 
and Ti6AlV4. These were implanted as solid rods in the rat gluteal muscle. No 
local malignancies arose and there was no significant difference in generalised 
tumour rates between implanted rats and controls. Memoli et al (1986) studied a 
number of alloys implanted intraosseously as solids, powders or fibres. They 
noted a slight increase in implant site malignancies with powders and fibres o f 
cobalt-chromium-nickel alloys but not with solid implants.
It is also worth noting that a number of other animal studies looking 
principally  at the toxicity o f orthopaedic alloys have also lacked evidence o f 
tumour formation. Thus, although there is strong evidence of the carcinogenicity 
of individual metals in animals, the evidence from studies looking specifically at 
orthopaedic alloys in anim als under experim ental conditions is conflicting.
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There are however, a number of reports in the veterinary literature 
o f osteosarcoma associated with bone plates inserted for the treatment of fractures 
in dogs (Stevenson et al, 1982).
1.4.3 Implant-associated malignancy in patients: a case report.
Much of the recent interest in the carcinogenic risks of orthopaedic 
materials has arisen from the ever increasing number of reports of malignancies 
associated with metal implants in clinical practice. The following case is reported 
by kind permission of Mr. A.L. Gunn F.R.C.S.
In September 1975, a sixty-two year old man was admitted as an 
emergency following a road traffic accident in which he suffered multiple injuries 
including fractures of the right humerus and olecranon, multiple rib fractures, 
fracture of the neck of the right femur and a compound fracture o f the shaft of the 
right femur.
After a prolonged period o f in-patient treatm ent, the soft tissues 
healed and the fractured shaft of femur was fixed with a Kuntscher nail and bone 
grafting. As with his other fractures, the femoral shaft fracture then went on to 
unite uneventfully. Thereafter he appeared to do well despite malunion o f the 
femoral neck fracture.
He was not seen again until July 1990 when he presented with a 
swelling in relation to the upper end of his right femur. Radiographs revealed a 
lytic lesion in the proximal femur (Fig. 1.3). The swelling was explored and found 
to consist of a large mass of necrotic material arising from the femur and almost 
surrounding the intramedullary nail. Tissue sent for histological examination 
showed the features of an osteosarcoma (Fig. 1.4).
19
F ig .  1 .3  Radiograph o f  right hip and femur 15 years after Kuntscher nailing. 
There is a lytic lesion eroding the cortex o f  the proximal fem ur in close 
proximity to the nail.
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Fig. 1.4 Histological specim en from patient in Fig. 1.3 The cells 
are p leom orphic with hyperchrom atic  nuclei and eosinophilic 
cytoplasm. There  are spindle cells, other b izarre  forms and 
osteoclast-like giant cells. The features are those o f  an 
osteosarcom a. (H & E, x250).
2 1
1.4.4 Implant-associated malignancy in patients: review of the literature.
In the past there were sporadic reports of carcinoma associated with 
retained m etallic foreign bodies in the lung (Siddons and M cA rthur, 1952). 
Before 1980 there were only four reports of tumour associated with orthopaedic 
im plants. In the last decade however, a num ber o f new cases have em erged. 
These are summ arised in Tables 2 and 3. Also included are four o therw ise 
unpublished cases recently reported by the Journal o f  Bone and Jo in t Surgery 
(Goodfellow 1992). To date there appears to have been 30 such cases in total, 
including the case reported in this thesis. Twenty have involved jo in t replace­
ments and ten have involved fixation devices.
Three reports cited in the litera ture  are not included. The case 
mentioned by Arden and By waters (1978) is almost certainly the same as that 
reported by Swann (1984). The case described by Kolstad and Hogstorp (1990) 
was a secondary deposit from a primary gastric carcinoma. Although the surgical 
trauma of joint replacement may have predisposed to the site of the metastasis, it 
clearly cannot be contemplated as "implant-associated" in the same way as the 
other reported primary tumours. Rushforth (1974) reported on a patient who 
developed an osteosarcoma of the pelvis six months after total hip replacement 
who had also had radiotherapy for carcinoma of the cervix nineteen years previ­
ously. This was most probably a case of post-irradiation malignancy.
With respect to the nature of the tumours, there is clearly no uni­
formity of tumour histology. The majority are sarcomata, but there are also two 
cases o f lymphoma. The single most common tumour type is malignant fibrous 
histiocytom a, which is of particu lar in terest as it has been postulated that this 
tumour may arise from a chronic reparative process (M irra et al 1974, Dunham 
and Wilborn 1979).
The types of implants are also diverse and the alloy composition is
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not clear in some cases. The majority were made from cobalt-chromium alloy or 
stainless steel. One had aluminium oxide ceramic components. Only one case 
definitely had a titanium alloy component (Troop et al 1990). However this was 
the last in a series of prostheses inserted over many years the previous ones being 
cobalt-chromium alloy. Of the cases where the alloy composition is not stated, 
judging from the dates and types of implant, it is unlikely that they were made 
from titanium.
Two o f the reports made note o f gross corrosion o f the im plants 
(McDougall 1956, Dube and Fisher 1972), and in the cases of Bauer et al (1987) 
and Ward et al (1990), the tumour tissue was found to have excess levels of metal 
on spectroscopic examination.
It is generally accepted that the induction of malignant change by 
chemical carcinogens in humans usually involves a long latent period between 
exposure and the manifestation of the malignancy. In 15 of the reported cases 
the latent period was ten years or more and in the case of Ryu et al (1987) fixation 
screws had been in place for 12 years before hip replacement. In several o f the 
others the interval was exceedingly short, casting doubt on the role of the metal in 
these patients.
Some cases had additional factors which may have contributed to 
the risk o f malignancy. In W eber's patient there was a bone in farc t present 
preoperatively in the distal femur, a condition known to have an association with 
m alignant fibrous histiocytom a (M irra et al, 1974). The patien t reported  by 
Dodion et al had previously had an infected fixation device at the same site. The 
risk of squamous carcinoma in osteomyelitis sinuses is well known and sarcoma 
has also been reported in association with bone infection (Akbamia et al, 1976). 
The patient described by Troop et al had multiple revision procedures over many 
years, a prosthetic infection and a previously diagnosed bone infarct at the site 
of .pathe tumour.
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Review of the known cases therefore reveals no definite correlations 
between implants and local malignancies. The number o f reports, although in­
creasing, remains very small in relation to the large numbers of implants in use.
1.4.5 Epidemiological studies in patients with joint replacements.
As pointed out by Black (1986), two additional factors should be 
considered. Primary bone tumours are very rare, accounting for only 0.25% of 
all primary tumours, which is equivalent to an incidence of around one per million 
of the adult population. Any increase in risk would therefore have to very large 
to be noticeable.
Alternatively, it may be that metal implants could increase the risk 
of tumour development in other more sensitive tissues. Investigating this possibil­
ity, Gillespie et al (1988) conducted the first epidemiological study of the inci­
dence of all cancers following total hip replacement. In a series of 1358 patients 
treated between 1966 and 1973, the incidence o f cancers o f the lymphatic and 
haem opoietic systems was significantly greater than expected in the ten years 
following hip replacement, while over the same period there was a significant 
reduction in the rates of other cancers such as those o f the breast, colon and 
rectum. While rightly advising caution in the interpretation o f these results, the 
authors tentatively suggested a mechanism of "chronic stimulation of the immune 
system , encouraging the em ergence o f lym phoreticular m alignancies but, by 
increasing immune surveillance, inhibiting the overt development of some epithe­
lial cancers." A second study (Visuri and Koskanvuo 1991) produced remarkably 
similar results. In 433 patients followed for a mean of 10 years after McKee- 
Farrar all-m etal total hip replacem ent, the risk o f developing leukaem ia and 
lymphoma increased while that of breast carcinoma decreased.
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These studies suggest that patients with total hip replacements may 
have a different susceptibility to cancer from the general population. Alternative­
ly, it is possible that patients with arthritis have a different predisposition. A 
number of possible variables must be considered in the interpretation o f epidemio­
logical studies but the results of these early studies are sufficiently intriguing to 
justify more investigations of this type.
1.5 Aims of this study.
The foregoing sections have attempted to summarise the develop­
ments and present knowledge of the biocompatibility of metal orthopaedic im ­
plants with particular reference to the risk of implant-induced cancer. Recent 
interest in this subject is reflected in three editorials published by the Journal of 
Bone and Joint Surgery. In the first, which followed three reports o f tumours 
arising in the vicinity of total hip replacements, Hamblen and Carter (1984) stated 
that "the number o f reported cases of sarcoma is so minute, compared with the 
vast number of replaced hips, that no surgeon or patient should feel undue con­
cern on this account..." . In the second, entitled "Malignancy and jo in t replace­
ment: the tip of an iceberg?", Apley (1989) called for all surgeons to report inci­
dences o f tum ours associated with jo in t replacem ents and said "O ur aim is to 
discover if  the association between replacement and local malignancy is purely 
coincidental and if not, to estimate the incidence of m alignancy...". The most 
recent (Goodfellow 1992) publicised the result of this request which amounted to 
five new cases of malignancy. It was concluded that "no large iceberg has been 
revealed..." but that "it may be wise to suggest a verdict of 'not proven' rather 
than 'not gu ilty '..." .
The ultimate answer to this question will come from the collective 
efforts and experience of orthopaedic surgeons and scientists in the fields o f
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biocompatibilty and cancer research. In the meantime a method o f grading the 
relative risks of the various metals in current use would be of help in the rational 
choice of the safest implant materials.
This project therefore set out to examine the potential toxicity and 
carcinogenicity of the commonly used orthopaedic metals. It used cell culture 
system s designed to assess the ability o f chem icals to induce changes in cell 
morphology and growth characteristics which are thought to be of importance in 
the carcinogenic process. Both human and animal cell systems were used, and the 
aims of the study were:
1. To demonstrate if certain cellular mechanisms associated with carcinogenesis 
could be induced by any, some, or all of the metals in question.
2. To establish, if possible, the relative risks of the individual metals and alloys 
in terms of toxicity and carcinogenicity.
3. To study the effect of the physical form in which the metals were presented.
4. To investigate the relationship, if any, between toxicity and carcinogenicity for 
each metal.
5. To compare the results in the human and animal cell systems in order to assess 
the value of each in considering the clinical situation.
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CHAPTER TWO
THE USE OF SHORT TERM IN VITRO CARCINOGENICITY ASSAYS
2.1  M ethods of detecting carcinogenic risk: the rationale of cell culture  
techniques.
Many of the substances now recognised as carcinogenic in humans 
were originally identified by the careful correlation o f clinical observations and 
epidemiological studies of populations at risk. These methods remain of foremost 
importance in cancer research but require painstaking efforts in their construction 
and interpretation, and of course involve continued exposure of people to poten­
tially dangerous materials. Even when the clinical and epidemiological evidence 
is incontrovertible as with tobacco, the precise identity and mechanism of action 
of the responsible agent or agents may remain uncertain. Other methods of inves­
tigation are needed.
Long term bioassays of carcinogenicity in experim ental anim als 
involve prolonged observation of animals over a substantial part of their lifetimes 
after or during continued exposure to suspected agents. Such studies allow the 
testing of a wide variety of agents with more precise manipulation of the methods 
of exposure. However they are time consuming, expensive and have extensive 
requirements for their construction and implementation, both for scientific and 
legal reasons. The great majority of such experiments are carried out on rodents, 
selected because of their availability, short lifespans and cheapness. Much has 
been learned from these studies, but the interpretation of their results must allow 
for all the possible interactions in a complex organism. Larger mammals such as 
non-human primates have none of the advantages of rodents and there is no indica­
tion that they would provide results more relevant to the human population.
For these reasons, great efforts have been made in recent years in
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developing short term in vitro methods of carcinogenicity testing, both to study 
the cellular mechanisms of carcinogenesis and to allow rapid screening of chemi­
cals and materials for carcinogenic risk.
Tissue culture originated in the early part of this century with the 
use of relatively crude methods to study growth from tissue explants (Harrison 
1907). Since then it has evolved into a highly specialised field with sophisticated 
techniques for the study of basic cellular mechanisms. The major advantage o f 
cell culture is the control it permits over the physicochemical and physiological 
environment of the cell. In addition, the development of specialised cell lines 
with homogenous characteristics minimises variability in response. Finally, the 
facility to use materials and reagents in small quantities affords advantages of 
economy. The main disadvantage of cell culture is the expertise required to avoid 
infection and maintain suitable environmental conditions. Despite this, there has 
been a massive explosion in the use of cell culture methods in the last 30 years, 
p a rticu la rly  in the field o f cancer research . To quote V asiliev and G elfand 
(1981), "It would hardly be an exaggeration to say that the main achievements of 
cancer cell biology during the last two decades have been associated with the use 
of cell cultures."
2.2 The effect of metals in short term in vitro carcinogenesis assays.
Over the last 20 years or so, a number of in vitro methods have been 
developed to study the actions and mechanisms of carcinogens at a cellular level. 
These have allowed the identification of specific endpoints which can be used as 
indicators of carcinogenic potential. They include studies of bacterial mutagene­
sis, mammalian cell mutagenesis, chromosomal damage and DNA damage. A 
large number of metals have been studied using these systems but the following 
review will be restricted to metals of orthopaedic interest.
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2.2.1 Bacterial mutagenicity assays.
Bacterial mutagenicity assays involve the manipulation of the growth 
requirements of the organism. Certain strains may need a particular amino acid in 
the growth medium for survival and in its absence no colonies will form. Howev­
er, some strains have the capacity to change their growth requirements by muta­
tion and when treated with a mutagenic agent will be able to form colonies in the 
deficient medium. The "Ames test" (Ames et al 1973a, 1973b) has been the most 
popular o f these assays and measures reverse m utation in h istidine dependent 
strains of Salmonella typhimurium. A similar assay utilises tryptophan dependent 
strains of Escherichia coli. Chromium in its hexavalent, but not in its trivalent 
form , has been found to be mutagenic in both the S .typhim urium  and E .coli 
assays (D eFlora et al 1980, Venier et al 1982). However, nickel compounds 
known to be carcinogenic from other studies are not mutagenic in either assay 
(Sunderm an 1981). Bacterial systems appear to be more reliable in detecting 
organic carcinogens than inorganic carcinogens (Costa 1980), and therefore have 
been of limited value in the study of metal carcinogenesis.
2.2.2 Mammalian cell mutagenicity assays.
The inherent differences between prokaryotic and eukaryotic cells 
place obvious limitations on the use of bacterial mutagenicity assays as screening 
methods for human carcinogens. The observation that various genetic changes, 
including gene mutation, occur in human tumour cells provides a rational basis for 
the use of assays to detect such changes in mammalian cell systems. Various 
metals have been studied in the V79 Chinese hamster cell system. This tests for 
mutagenicity at the hypoxanthine-guanine phosphoribosyl transferase (HGPTR) 
locus by selecting for 8-azaguanine resistance. Normal cells with HGPTR activity 
convert 8-azaguanine to toxic metabolites which cause cell death. Mutant cells
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lose HGPTR activity and therefore survive. Miyaki et al (1979) found that be­
ryllium caused a six-fold increase in resistance and that cobalt and nickel caused a 
two to four-fold increase. Hsie et al (1980) tested the mutagenicity o f metals in 
Chinese hamster ovary (CHO) cells and found that among others, iron and nickel 
were mutagenic while titanium was not. Tests for induction of trifluorothymidine 
resistance at the thym idine kinase locus in mouse lym phom a cells have given 
positive results with nickel and hexavalent chromium and negative results with 
cobalt and aluminium (Amacher and Paillet 1980, Oberly et al 1982).
2.2.3 Chromosomal aberrations.
As with gene mutation, chromosomal aberrations such as transloca­
tions and deletions have been observed in tumour cells. Chromosomal alterations 
often lead to cell death but some such alterations allow cell survival and may be 
involved in the process of neoplastic change. Chemicals that induce structural 
chromosomal abnormalities are known as clastogens and various systems have 
been developed to detect such clastogenic effects. These are classified into two 
main groups - deletions and rearrangements of chromosomes, or sister chromatid 
exchanges (symmetrical exchanges of segments within a single chromosome). 
The clastogenic effects of metals have been demonstrated in a number of studies. 
Umeda and Nishimura (1979), using a mouse mammary carcinoma cell line found 
that nickel and hexavalent chromium compounds induced chromosomal aberra­
tions while trivalent chromium did not. Larramendy et al (1981) observed that 
nickel caused chromosomal damage and increased frequencies o f SCE in both 
Syrian hamster embryo cells and human lymphocytes. Ohno et al (1982) found 
that nickel and chromium compounds produced increased num bers o f sister 
chromatid exchanges in Chinese hamster cells whereas titanium and iron did not.
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2.2 .4  DNA dam age.
On the basis that carcinogenic agents exert their prim ary effects at 
the level of the DNA molecule, a great many methods of measuring the interac­
tions of chemicals with DNA have been developed. These include measures of 
DNA binding, DNA strandbreaks and crosslinks, transcription infidelity and DNA 
repair mechanisms. A full account of these techniques is outwith the scope of this 
work but the results of studies of metals in these systems is reviewed by Sunder- 
man (1984). Of the metals used in orthopaedic implants, chromium, nickel and 
cobalt have been shown to have damaging effects on DNA.
In summary then, these studies demonstrate that some of the metals 
used in orthopaedic practice are capable o f causing various types o f genetic 
damage indicative of carcinogenic potential.
2.3 In  vitro cell transform ation.
While many advances have been made through the use of the meth­
ods discussed in the previous section, they are largely based on the theoretical 
correlation between the measured endpoints and the carcinogenic process. This 
does not detract from their usefulness in studying cellular mechanisms, but does 
place limitations on their use as screening tests. For example, it can be said that 
all carcinogens are mutagens but it cannot be assumed that the reverse is true.
It is now generally accepted that carcinogenesis is a m ultistage 
process. This is borne out by a large amount of experimental evidence and is 
reflected in clinical observations such as the long latent period between exposure 
to carcinogens and tumour development, and the existence of various premalig- 
nant conditions which precede human and experimental cancers. These considera­
tions indicated the need for test systems in which the measured endpoints had a
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direct bearing on the natural history of cancer development in vivo , and led to the 
development of cell transformation assays.
Tum our growth in an animal is the result o f a breakdow n in the 
normal regulation of cell proliferation in the involved tissue. This leads to the 
development of recognisable alterations in behaviour such as abnormal differentia­
tion, loss of normal histology and, in the case of malignant tumours, invasion of 
surrounding tissues and spread to secondary sites. Cell transformation assays 
attempt to mimic such changes within the confines of cell culture conditions. Cell 
transformation can therefore be defined as the induction in cultured cells of certain 
phenotypic alterations that are related to the carcinogenic process. They include 
morphological transformation, focus formation on cell monolayers, aquisition of 
indefinite lifespan, growth in semisolid media and altered growth requirements. 
These changes have been shown to be associated with neoplastic conversion of 
certain cell types by virtue of their ability to produce tumours in experimental 
animals.
The first demonstration of in vitro transformaton was reported by 
Berwald and Sachs (1963, 1965). They exposed primary and secondary cultures 
o f Syrian ham ster em bryo cells to two carcinogenic arom atic hydrocarbons, 
benzo[a]pyrene and 3-methylcholanthrene, and continued to subculture the cells. 
Untreated cells exhibited a limited lifespan and underwent senescence after about 
four passages, whereas treated cells, after prolonged culture, developed foci o f 
rapidly dividing cells capable of continuous proliferation. Injection of these trans­
formed cells into hamsters produced tumours with the histological appearances of 
sarcomas.
Many o f the properties of transform ed cells are the result o f cell 
surface m odifications which lead to changes in their grow th characteristics. 
Normal untransformed cells require a solid substrate on which to grow (anchorage
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dependence). When the available surface has been covered, cell division stops 
(contact inhibition or density limitation o f growth). Transformed cells, possibly 
as a result of alterations in cell surface proteins, may lose these inhibiting features 
and develop the ability to grow in semisolid media such as soft agar (anchorage 
independent growth), or form foci of continued cell growth on confluent monolay­
ers. These features form the basis of many of the cell transformation assays in 
current use.
2.4 The C3H/10TV2 mouse embryo fibroblast cell transformation assay.
In 1973, Reznikoff et al (1973a) reported on the establishment and 
characterisation o f a perm anent mouse fibroblast cell line derived from C3H 
mouse embryo cells, termed C3H/10TV2 clone 8, so called because the line was 
established using a ten-day transfer schedule with an inoculum of 0.5 x 105 cells 
per dish. These cells are near tetraploid, have a low saturation density, and are 
highly sensitive to post confluence inhibition of division. A second paper (Rez­
nikoff et al 1973b) reported on the neoplastic transformation of these cells by 
po lycyclic  a rom atic  hydrocarbon carcinogens. T reatm ent o f the cells w ith 
benzo[a]pyrene, 3-methylcholanthrene or 7,12-dimethylbenz[a]anthracene induced 
foci of deeply staining cells which stood out against the faintly stained background 
monolayer when the cells were stained with Giemsa. Three types of foci were 
identified.
Type I foci show an increase in cell density and darker staining, but 
there is little or no multi-layering. The edge is poorly defined and blends into the 
background monolayer (Fig. 2.1).
Type II is a focus of piled up deeply staining cells with a well de­
fined edge which stands out against the background (Fig. 2.2).
Type III is again a multi-layered deeply basophilic focus, but the
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peripheral cells are spindle shaped, randomly orientated and appear to invade the 
monolayer (Fig. 2.3).
Cells from each type of focus were inoculated into irradiated synge­
neic mice to test for tumour formation. Cells from Type I foci did not produce 
tum ours, therefore Type I foci are not counted as transform ed in the assay. 
Approximately 50% of Type II foci and 80% of Type III foci produced sarcomas 
in inoculated mice, therefore both Type II and Type III foci are counted as malig­
nantly transformed.
The C3H/10TV2 transformation assay was investigated by a w ork­
ing group commissioned by the International Agency for Research on Cancer 
(IARC 1985). It reviewed the collective experience o f this assay and made 
recommendations regarding the experimental protocol in performing the assay. 
These recommendations were followed in the course of this study and are de­
scribed in detail in the materials and methods section. As with all techniques, the 
assay has strengths and weaknesses and these are considered in the discussion of 
the results.
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Fig. 2.1 Type I focus.
a) increased cell density but no multi-layering.
b) poorly defined edge blends with monolayer.  
(Giemsa,  a) x40 b) x200).
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Fig. 2.2 Type II focus.
a) multi-layering and dark staining o f  cells.
b) well defined edge.
(Giemsa,  a) x40 b) x200).
Fig. 2 .3  Type III focus.
a) mult i-layered deeply basophilic cells.
b) peripheral  cells are spindle shaped and criss-cross  randomly.  
(Giemsa,  a) x40 b) x200).
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2.5 Induction of anchorage independent growth in diploid human fibroblasts.
A central problem  in cancer research is the extrapolation o f the 
knowledge obtained from laboratory and animal experiments to humans. In vitro 
models using human tissues and cells provide an obvious avenue towards solving 
this problem. Techniques for culturing many human cell types are widely avail­
able, but for the purposes of carcinogenesis research, the inherent genetic stability 
of human cells in culture systems has, so far, delayed the development of human 
cell transformation systems. The reasons for this are discussed in more detail in a 
later section. However, human fibroblasts have been "transformed" in culture by 
a variety of methods to produce growth characteristics similar to those seen in 
rodent cell systems. These changes in human cells have not been clearly shown to 
be representative of carcinogenic change, not least because of the moral difficul­
ties in testing them in the natural host, and at present are considered to indicate 
stages in the carcinogenic process (Harris 1987).
In 1987, Biedermann and Landolph reported the induction o f an­
chorage independent growth in human fibroblasts by metal salts. Cells treated 
with compounds of chromium, nickel and arsenic developed the ability to form 
colonies in semisolid agar medium whereas control cells did not. This was the 
first study to show that transformation-like changes can be induced in human cells 
by metals and it was therefore felt that this technique would be a valuable addition 
to this study.
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CHAPTER THREE 
MATERIALS AND METHODS
3.1 The C3H/10TV2 cell transformation assay: maintenance of cells, staining 
method and preparation of test metals.
3.1.1 Routine maintenance of C3H/10T1/2 cell stocks.
C3H/10TV2 clone 8 cells, grown and maintained for the purpose of 
transform ation studies, were obtained at passage 8 from  the Am erican Tissue 
Culture Collection via the Public Health Laboratory Service, Porton Down. On 
receipt of the cells, stocks were rapidly expanded and stored frozen in liquid 
nitrogen at -196°C. Cells were then resurrected as required for perform ance of 
cytotoxicity and transformation studies. Stock cultures were grown in 75cm2 
tissue culture flasks, in Eagle's Basal Medium with E arle 's salts (EBME), sup­
plem ented with 10% foetal calf serum (FCS) and L-glutam ine 292.3 /xg/ml, 
without added antibiotics. Cells were grown in a humidified incubator at 37°C in 
a 5 % CO? atmosphere.
During routine maintenance, cells were seeded at 5 x 104 cells per 
75 cm2 flask and maintained in the exponential growth phase by reseeding every 
seven days, or as necessary before reaching confluence. Stocks were discarded at 
passage 15 to avoid possible increases in spontaneous transformation rates. In 
practice, due to restrictions on incubator space and the practicalities of handling 
large num bers o f cultures at once, cells w ere seldom used beyond P13. All 
manipulations of cells were undertaken in class II vertical laminar flow cabinets. 
Cells were stained with Hoechst 3325 8(S) and found to be mycoplasma free.
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3.1.2 Cell transfer and counting.
Culture medium was removed and the cells washed with phosphate 
buffered saline. 10ml. 0.25% trypsin in phosphate buffered saline (PBS) was 
added for 30 seconds then all but 0.5 ml. was removed and the cells incubated at 
37° for a further two minutes. Detachment was confirmed microscopically and 
the cells then doused with 9.5 ml. of complete medium to neutralise the trypsin. 
Cells w ere then evenly suspended and a small am ount taken for counting in a 
haemocytometer.
3.1.3 Freezing and storage of cells.
Cells were harvested as above and counted. The suspension was 
then centrifuged at 2000 rpm for 10 minutes at 4°C to form a pellet at the bottom 
of the centrifuge tube. The supernatant was removed and the cells resuspended in 
lm l. of freezing medium, i.e. complete medium containing 10% Dimethyl Sulph- 
oxide (DMSO). The suspension was transferred to a plastic cryotube which was 
then packed in a polystyrene box and frozen slowly over 24 hours in a -70°C 
freezer. Tubes were then transferred to a liquid nitrogen container for permanent 
storage. F or resurrection, tubes were rem oved from liquid nitrogen , rapidly 
thawed in a w ater bath at 37°C, and transferred  to culture flasks w ith added 
medium. Medium was changed 24 hours later to remove excess DMSO.
3.1.4 Determination of cell growth characteristics.
Plating efficiency was determined by seeding cells at 200 cells per 
60mm well in four-well plates. Cells were then grown for 10 days changing the 
medium once, after which they were fixed in methanol and stained with Giemsa. 
Using a magnifying lens, colonies of over 50 cells were counted and the percent­
age plating efficiency derived by dividing the number of colonies formed by the
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number of cells seeded, multiplied by 100. The colony count was the average of 
the four wells.
Growth curves were constructed as follows. Cells were seeded at 
5 x l0 3 cells per 2cm2 well in 24-well plates. At 24 hour intervals thereafter, 3 
wells were trypsinised and the number of cells in each well counted. The average 
cell count was then converted to log10 and plotted against time on a semi-logar­
ithmic graph.
3.1.5 Staining method.
Staining of cells was carried out by the method recommended by 
Freshney (1987). Growth medium was removed and the monolayer rinsed with 
PBS. The PBS was removed and replaced with PBS and m ethanol in a 1:1 
m ixture. The PBS/m ethanol was removed and replaced with fresh methanol 
which was left for 10 minutes. The methanol was discarded and the monolayer 
rinsed with fresh anhydrous m ethanol. Neat Giemsa stain was then added to 
cover the monolayer and left for two minutes after which it was diluted 1:5 with 
water and left for a further two minutes. Wells were then washed in running tap 
water until all scum and precipitate was removed and finally, rinsed with deio­
nized water.
3.1.6 Preparation of metals.
The m ajor com ponents of the three com m only used orthopaedic 
alloys were tested, com prising cobalt, chrom ium , m olybdenum , iron , nickel, 
titanium, aluminium, and vanadium. Each was tested in two forms, firstly as a 
soluble salt o f either sodium or chloride, and secondly as the pure particu late  
metal. Chromium was tested in two soluble forms, the hexavalent (chromate) and 
the trivalent (chromium) form. In addition each alloy, cobalt-chromium-molyb-
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denum, stainless steel, and Ti6A14V was tested in particulate form.
Cobalt chloride (CoCl?) , chromium chloride (CrCl3), nickel chloride 
(NiCl2), vanadyl chloride (V O C y , and ferrous chloride (FeIICl2) were purchased 
from BDH Ltd. Sodium molybdate (Na2M o04) and aluminium chloride (A1C13) 
were purchased from Sigma Ltd. Titanium chloride (TiCl3), sodium chromate 
(Na2C r0 4), molybdenum particles (size 4-8jum), vanadium particles (325 mesh) 
and nickel particles (size < 3 ^m ) were purchased from Aldrich Chemical Co. 
Chromium particles (size < 2^m ), titanium particles (size <150/xm), iron parti­
cles (size <60jum), stainless steel particles (AISI 316, pre-alloyed, size <45/nm) 
and Ti6A14V particles (pre-alloyed, size <45^m ) were purchased from Goodfel- 
low Ltd. Cobalt particles (size l/xm) and aluminium particles (size <25^m ) were 
purchased from Kochlite Ltd. CoCrMo alloy particles (F75 standard, pre-alloyed, 
mesh 150-325) w ere a kind gift from H ow m edica Ltd. All com pounds and 
powders were of over 99% purity.
Test solutions and suspensions were prepared immediately prior to 
use. Metal salts were carefully weighed out on an analytic scale, calibrated to 
O.OOOlg accuracy, and dissolved in double distilled water. In the case of TiCl3 
which is highly volatile in air, aqueous solutions were made in a nitrogen atm o­
sphere cabinet. Stock solutions were sterilised by filtration through millipore 
filters. The desired test concentration was achieved by serial dilution, the final 
dilution being made in complete medium.
It has previously been shown that C3H /10T1/2 cells are capable of 
internalising particles by phagocytosis (Costa and Mollenhauer 1980, Patierno et 
al 1988). It was therefore decided to also test metal particles o f 5jiim or less. 
Attempts to filter metal particles through millipore filters with pore size 5jum were 
unsuccesful due to tearing of the filters by large particles. Suspensions o f parti­
cles o f the desired size were therefore prepared by sonication o f the metal pow­
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ders in acetone and allowing the larger particles to sink to the bottom of the test 
tube. Sm aller particles remaining in suspension in the upper fraction were then 
removed with the acetone and the acetone evaporated off. Particle size was con­
firm ed by microscopy using an eyepiece graticule and the process repeated as 
often as necessary to provide a sufficient amount. Particles were then heat steri­
lised and the final suspension made in double distilled water.
3.2 The C3H/10TV2 cell transformation assay: experimental design.
The C3H/10Tj/2 cell transformation assay was carried out following 
the recommendations of the I ARC working group (IARC 1985). The assay is per­
formed by exposing C3H/10TV6 cells to the test compounds as well as positive 
and negative controls for 48 hours. The cells are then cultured and examined for 
cytotoxicity and induction of phenotypic transformation.
3.2.1 Selection of dose levels.
The dose levels for the test metals w ere selected following prelim inary 
cytotoxicity tests based on estimation of plating efficiency using the method de­
scribed above. 200 cells per 60mm well in four replicates were exposed to sol­
vent alone and to increasing concentrations of metals for 48 hours. Cell survival 
was determ ined 10 days later and plating efficiency in the treated groups was 
expressed as a percentage of that in the solvent controls (relative plating efficiency 
RPE). When possible, the highest test dose was selected to give 80-90% toxicity 
and the lowest was the maximal nontoxic dose, with 2 to 3 intermediate doses 
added.
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3.2.2 Controls.
For the test metals the solvent control was double distilled water. 
The positive control was 3-Methylcholanthrene (3-MCA) at a final concentration 
o f 2.5 jug/ml. For treatment of cultures 3-MCA was dissolved in DMSO (final 
concentration 0.5%).
3.2.3 Preparation of target cells.
Each assay consisted of two limbs which were carried out concurr­
ently. For ease of handling of the large number of cultures required for the study 
and optimal use of incubator space, plates comprising four 60mm wells were 
used instead of individual 60mm dishes.
Exponentially growing C3H/10TV2 cells were seeded at 200 cells 
per 60mm well in four replicates for cytotoxicity studies and at 2000 cells per 
60mm well in 20 replicates for transformation studies. Seeding was carried out 
the day before treatment to allow settling and adherence of the cells. As with the 
stock cultures, cells were grown in EBME, supplemented with 10% FCS without 
added antibiotics in a humidified atmosphere of 5% C 0 2 in air at 37°C.
3.2.4 Treatment of target cells.
Concentrations of test compounds were prepared immediately prior 
to use in the appropriate solvent. 3-MCA was dissolved in DMSO and 50 (jl\ of 
the solution were delivered to the cultures by micropipette to give a final concen­
tration o f 2.5 fig/ml. In the case of metals, the last dilution (or suspension of 
particles) was made in complete medium, 1 ml of which was added to cultures to 
give the desired final concentration in 5 mis of medium. The day o f treatment 
was designated Day 0. Cells were exposed to test compounds or controls for 48 
hours following which treatment media were removed and replaced with 5 mis of
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complete medium. After this the medium was changed at least once a week for 
the duration of the assay.
3.2.5 Estimation of cytotoxicity.
Cells treated for cytotoxicity studies were grown for 10 days after 
which they were fixed and stained and the num ber o f colonies counted. The 
degree of toxicity of each treatment was measured as the relative plating effi­
ciency as compared with the control as described above. A typical cytotoxicity 
study is shown in Fig. 3.1.
3.2.6 Expression of transformed phenotype.
Cells treated for transformation studies were maintained in culture 
for six weeks. After this period the wells were fixed with methanol, stained with 
Giemsa and scored for morphologically transformed Type II and Type III foci 
using the method and criteria described below. Control transformation assays are 
shown in Fig. 3.2.
3.2.7 Validation of the assay.
It is known that C3H/10TJ/2 cells require specific batches o f foetal 
calf serum to attach properly and grow optimally in culture (Landolph 1985). In 
addition, some batches of FCS yield good plating efficiencies but do not support 
transformation with 3-MCA (Oshiro et al 1982). It is therefore necessary to pre­
screen serum batches before use to ensure that they support both the required 
growth characteristics and morphological transformation. According to the IARC 
protocol, the plating efficiency of the solvent control should optimally be 30% and 
no less than 20% , and the population doubling tim e in the exponential phase 
should be 17-20 hours. In transformation studies, the negative control should not
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Fig. 3.1 Cytotoxicity as shown by relative plating efficiency. 
There  are numerous colonies in the control wells (left). After  
treatment  with VOCfi 1/ig/ml (right) the surviving colony count  
is greatly reduced.
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Fig. 3.2 Transformation assay controls.
Left: 3 -MCA 2.5/ug/ml. There  are numerous  t ransformed foci. 
Right: DM SO  0 .5% .  The cells remain contact  inhibited with no 
focus formation.
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exhibit spontaneous transformation frequencies of more than 0.07 foci per dish, 
and the positive control should induce a significantly (P < 0 .05 ) greater number of 
transform ed foci than the negative control. In this study, only serum batches 
which met these criteria were used. For the batch screening assays the positive 
control was 3-MCA 2.5 ^g/m l and the negative control was DMSO 0.5%.
3.2.8 Scoring of foci.
On completion of an assay, the plates were fixed, stained and stored 
for later scoring. When a sufficient number o f assays had been completed, the 
p lates w ere coded and scored blind for form ation o f type II and type III foci. 
Scoring was done by eye using a magnifying lens. Foci that appeared intermedi­
ate in character (I/II or II/III) were assigned to the less aggressive category. The 
total number o f type II and type III foci for each treatment was recorded. The 
transformation frequency for each treatment was taken as the number o f wells 
with foci divided by the total number of wells scored. The difference between 
treatments and controls was evaluated statistically using Fisher's exact probability 
test.
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3.3 Induction of Anchorage Independent growth in Human Fibroblasts.
In 1987, B iederm ann and Landolph described  the induction  o f 
anchorage independent growth in human foreskin fibroblasts by metal salts. As 
part of the interest of this study was the possible carcinogenic effects of metals on 
periarticu lar tissues, it was decided to attem pt to use this method with human 
synovial fibroblasts as well as human foreskin fibroblasts.
3.3.1 Source and preparation of cells.
Primary cultures of human synovial fibroblasts were grown from 
specim ens of synovial tissue removed from patients in the course o f surgical 
procedures. Synovium was removed under aseptic conditions and transported to 
the laboratory in Minimum Essential Medium with Hank's salts (HMEM). It was 
then im m ediately minced into small pieces with a scalpel. The explants were 
transferred to culture wells containing complete medium and incubated in a 5% 
C 0 9 atmosphere at 37°C. Cultures were examined periodically to confirm cell 
outgrowth from the explants and were grown until the monolayer approached 
confluence. The explants were then removed and the monolayer was trypsinised. 
Cells were transferred to flasks at a 1:3 split and were harvested and frozen at 
passage 3. Primary cultures of human synovial fibroblasts were prepared in this 
way using synovium obtained from a 9 year old patient undergoing open reduction 
of a congenitally dislocated hip. Human foreskin fibroblasts were a kind gift from 
Dr. J. Wright (Rheumatology Research Unit, Addenbrooke's Hospital). These 
were originally grown from circumcised infant foreskins. Methods o f cell trans­
fer, freezing and resurrection, and routine m aintenance w ere sim ilar to those 
described previously for C3H/10TV2 cells.
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3.3.2 Experimental method.
C ytotoxicity assays were carried out using the same plating e ffi­
ciency method as described for C3H/10TV2 cells. Metal salts and particles were 
also prepared by the same method as described previously.
Assays for induction of anchorage independent growth were carried 
out by seeding cells in semi-liquid agar medium onto a base of solid agar medium, 
after exposure to test chemicals, as follows. 105 cells were seeded into 75cm2 
flasks and 24h later were treated with test chemicals for 48h. The medium was 
then removed and replaced with fresh medium. Cells were subcultured as neces­
sary to maintain exponential growth and at 12 days, the cells were trypsinised and 
suspended in 3 ml of 0.3% agar noble mixed with double strength growth medium 
in a 1:1 mix. Growth medium consisted of HMEM supplemented with non-essen­
tial fatty acids, hydrocortisone (50 jug/ml), insulin (0.15 units/ml), 10% foetal calf 
serum, and 10% tryptose phosphate broth. The cell suspension was placed on top 
o f 5 ml of a 0.5% agar base layer containing growth medium in 60mm wells in 
four replicates and incubated in a 5% C 0 9 atmosphere at 37°C. Cells were fed 
every 6 days with 0.5 ml of HMEM containing 15% FCS. Four weeks later, 
cells were stained with 1 mg/ml iodonitrotetrazolium violet in PBS and examined 
m icroscopically for colonies greater than 0.1 mm in diam eter. The positive 
control for the assay was the known carcinogen N-methyl-N'-nitro-N-nitrosogua- 
nidine (MNNG) dissolved in acetone (final concentration of acetone 0.5%) and the 
negative control was acetone 0.5%.
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CHAPTER FOUR 
RESULTS
4.1 Validation of serum batches in C3H/10TV2 cell cultures.
Four batches o f foetal calf serum w ere used in the course o f the 
study, namely NBL batch 19827, Imperial batch 960585, Gibco batch 06G9982Y 
and SeraLab batch 801053.
4.1.1 Cell growth characteristics.
During batch testing, they yielded plating efficiencies of 50.4% , 
50.4% , 43.7% and 51.9% respectively. Growth curves were similar for each 
batch with population doubling times of 12-14 hours.
4.1.2 Cell transformation.
Transformation assays confirmed that all four batches supported 3- 
methylcholanthrene-induced transformation with transformation incidences of 
12/20, 14/20, 14/20 and 18/20 respectively. In dimethyl sulphoxide controls, 
none of the batches produced spontaneous transformation frequencies in excess of 
the recommended limit of 0.07 foci per well.
The results of these validation studies are shown in more detail in
Appendix A.
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4.2 Results of metal salts in the C3H/10TV2 transformation assay. Cytotoxi­
city and transformation incidence.
In the following account, the results are given for each metal salt
individually. As explained in the methods section, each assay is double-limbed,
consisting of cytotoxicity and transformation assays carried out concurrently for 
each concentration. The result given for each salt is the combination of two such 
double-limbed assays and is shown both as a table of values and a graph. In the 
table, the relative plating efficiency for each concentration is the average o f two 
results and the transformation incidence is the sum of two results. In the graph 
the transformation incidence is expressed as a percentage value. The separate 
results for each cytotoxicity and transformation assay can be found in appendices 
B and C respectively. Metals were considered to be transforming if the transfor­
mation incidence reached the 0.05 level of significance at any concentration level 
compared with the negative control (F isher's exact probability test, one-tailed 
method).
In such a system measuring two outcomes for each test, four types
of result are possible for the substances being tested. They may be toxic and
transforming, non-toxic and transforming, toxic and non-transforming or non­
toxic and non-transforming. Metal salts fell into each of these categories and are 
presented in that order.
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4.2.1 M etals which were toxic and transform ing.
C obalt Chloride (Fig.4.1).
CoCL, was tested at concentrations o f 0 .1 , 1, 5, 10 and 20 jug/ml, 
and demonstrated increasing toxicity and transformation in a dose related fashion. 
Even at the lowest concentration of 0.1 jug/ml, there was noticeable toxicity with a 
relative plating efficiency of 78.8%. Although the R.P.E. at the highest concen­
tration of 20 jitg/ml was only 0.2%, enough cells survived the exposure period to 
form a confluent m onolayer during the six week course o f the transform ation 
assay. The incidence of transformation became significant at 5 fig/m\ (p =0.001) 
and became more so at higher concentrations, though it can be seen from the table 
and the graph that there is an increasing trend throughout the test range. It will be 
noted that all the transformed foci were of type II morphology.
Nickel Chloride (Fig.4.2).
NiCL, was only slightly less toxic than C oC l2, showing minimal 
toxicity at 1 fig/ml and maximal decrease in plating efficiency at 40 fig/ml, with 
intermediate effects at 10 and 20 fig/ml. A further increase to 60 fig/ml produced 
similar effects as the 40 jug/ml level. Again at the maximally toxic levels, enough 
cells survived to form monolayers in the transformation assay. Significant in­
creases in transformation were seen at 10 (p =0.014) and 20 fig/ml (p = 0 .003), 
but ju s t failed to reach significance at 40 and 60 fig/m l (p = 0 .0 5 4 ). As with 
CoCL,, all the transformed foci were type II.
Chrom ium  Chloride (Fig.4.3).
CrCl3 was tolerated in much higher concentrations with no toxicity 
at 300 fig/ml, but increasing cell death at 600 and 900 fig/m\. At 1200 fig/ml  
however, CrCl3 precipitated out of solution accompanied by the appearance of
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denatured aggregates in the culture medium to varying degrees. This may account 
for the marked discrepancy between the two cytotoxicity assays done at this 
concentration (see appendix B.). In addition there was clearly a delayed effect on 
cell grow th in the transform ation assay at 1200 /xg/ml. At 300, 600 and 900 
/xg/ml the monolayers were normal in appearance with the occurence of some type 
II foci though not enough to reach significance. However, at 1200 /xg/ml exten­
sive cell death and detachment of the monolayer from its surface occurred in the 
late stages of the assay, such that only 10 wells were available for scoring (appen­
dix C.). Despite this the transformation incidence reached significance (p=0.014) 
and two of the foci were of type III morphology. Whether this result was due to 
the C rC l3 alone or to some additional effect from the change in the culture 
medium during the exposure period is difficult to know.
Sodium Chromate ( F i g . 4 . 4 ) .
Na7C r0 4 was clearly the most toxic of all the metal salts tested with 
maximal toxicity at only 0.5 /xg/ml, minimal toxicity at 0.01 /xg/ml, and in ter­
mediate values at 0.05 and 0.1 /xg/ml. Significant transformation occurred only at 
the most toxic dose, though here it was quite marked with 10 out o f 36 wells 
having foci (p = 0.002). As can be seen from the table, there was quite a jum p 
down in plating efficiency between the 0.1 and 0.5 /xg/ml concentrations and it 
could be fairly argued that an interm ediate dose would have been helpful in 
demonstrating any dose related increase in transformation.
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Cobalt Chloride
8 0
R.P.E
Transformation
Incidence
0
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u  4 0  
0
O h
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0 5 10 20
Concentration /xg/m l
CoCl2
Mg/ml
R.P.E.(% ) Focus type 
II III
Transformation
Incidence
0.1 78.8 2 2/40
1.0 47.9 5 - 5/40 p= 0 .1
5.0 5.0 11 - 11/40 p=0.0016
10.0 1.0 13 - 12/39 p =0.0006
20.0 0.2 17 - 13/40 p =0.0003
Water 100.0 1 - 1/40
3-MCA 78.0 80 25 34/40
Fig. 4.1 Results of cobalt chloride in the C3H/10TV6 assay.
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Nickel Chloride
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v Transformation 
Incidence
20
0 10 20 30 40 50 60
Concentration f i g / ml
NiCl2
^g/m l
R.P.E.(%) Focus type 
II III
Transformation
Incidence
1.0 104.5 1 1/40
10.0 43.0 9 - 8/40 p=0.014
20.0 6.7 15 - 10/40 p =0.003
40.0 0.2 8 - 6/40 p=0.054
60.0 0.5 8 - 6/40
Water 100.0 1 - 1/40
3-MCA 78.0 80 25 34/40
Fig. 4.2 Results of nickel chloride in the C3H/10TV6 assay.
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Chromium Chloride
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Concentration /zg/m l
1200
CrCl3
j*g/ml
R.P.E.(%) Focus type 
II III
Transformation
Incidence
300.0 104.5 5 5/40
600.0 71.9 2 - 2/40
900.0 53.8 4 - 4/40
1200.0 35.6 13 2 8/40 p= 0 .014
Water 100.0 1 - 1/40
3-MCA 78.0 80 25 34/40
Fig. 4.3 Results of chromium chloride in the C3H/10TV6 assay.
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Sodium Chromate
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Incidence60
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0.0 0.1 0.2 0 .3 0 .4 0 .5
Concentration fj.g/m l
Na2C r0 4
Mg/ml
R.P.E.(%) Focus type 
II III
Transformation
Incidence
0.005 93.6 1 1/40
0.01 93.2 2 - 1/40
0.05 69.4 - - 0/40
0.1 45.7 3 - 3/36
0.5 0.2 12 - 10/36 p =0.002
Water 100.0 1 - 1/40
3-MCA 78.0 80 25 34/40
Fig. 4.4 Results of sodium chromate in the C3H/10TV2 assay.
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4.2.2 M etals which were non-toxic and transform ing.
Sodium M olybdate (Fig.4.5).
Only N a9M o 0 4 came into this category. It was tolerated in high 
concentrations up to 500 /ug/ml with virtually no sign o f toxicity. A significant 
transformation incidence was reached at 10 /xg/ml with 9/40 wells producing foci 
(p =  0 .007). Foci also occurred at the o ther concentrations but not in enough 
numbers to reach significance, and there was no trend to suggest that the effect 
was dose related. Once again most of the foci were type II but at 10 /xg/ml, three 
were type III in nature.
4.2.3 M etals which were toxic and non-transform ing.
Vanadyl Chloride (Fig.4.6).
VOC1., was only slightly less toxic than Na0CrO4 showing increasing toxi­
city at 0.1, 0.5 and 1 /xg/ml, with maximum toxicity at 5 fig/ml. Although there 
was some focus formation at 0.1 /zg/ml, two of which were type III, the transfor­
mation incidence did not reach significance, and there was no focus formation at 
the other concentrations. VOC1, was so toxic at 5 fig/ml that the monolayer was 
only just complete in some wells at the end of the transformation assay, i.e. colo­
nies were just merging. It is possible then that at this concentration there was not 
enough time for foci to form after completion of the monolayer.
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Sodium Molybdate
100
8 0
R.P.E
Transformation
Incidence
60
4 0
20
0
10°
Concentration /xg/m l
Na2M o04
Mg/ml
R .P.E .(%) Focus type 
II III
Transformation
Incidence
1.0 100.1 6 6/40 p =0.054
10.0 96.9 8 3 9/40 p =0.007
100.0 97.6 2 - 2/40
500.0 102.7 4 - 4/40
Water 100.0 1 - 1/40
3-MCA 81.8 44 27 28/39
Fig. 4.5 Results of sodium molybdate in the C3H/10T1/2 assay.
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R.P.E.(%) Focus type 
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Transformation
Incidence
0.1 87.8 1 2 3/36
0.5 52.8 - - 0/40
1.0 35.4 - - 0/40
5.0 0.0 - - 0/40
Water 100.0 2 - 2/40
3-MCA 83.9 52 16 26/39
Fig. 4.6 Results of vanadyl chloride in the C3H/10TV6 assay.
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4.2.4 M etals which were non-toxic and non-transform ing.
Ferrous Chloride (Fig.4.7).
FeIICl2 produced very little toxicity at concentrations o f 10, 50, 100 and 
200 /xg/ml, the R .P .E . at the highest concentration rem aining at 90 .2% . At 
concentrations above 200 /xg/ml, FeIICl2 precipitated out and led to more exten­
sive denaturing of the growth medium than that seen with CrCl3, resulting in no 
cell growth. Transformation foci occurred at all concentrations, but although two 
foci were type III, the transformation incidence failed to reach significance at any 
dose level.
Aluminium Chloride (Fig.4.8).
Similarly, A1C13 displayed little toxicity over a range from 1 to 500 /xg/ml, 
and again, although some foci appeared, the transformation incidence did not 
reach significance at any concentration.
T itanium  Chloride (Fig.4.9).
TiCl3 was tested at 10, 50, 100 and 500 fig/ml and again demonstrated very 
little toxicity. It should be noted that the R.P.E. of 79.9% at 500 /xg/ml is the 
result o f only one cytotoxicity assay as the other was lost to infection. M ore 
importantly, there were no transformation foci at any concentration level. TiCl3 
was the only metal tested to demonstrate this effect.
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Ferrous Chloride
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Concentration /xg/m l
FeIICl2
/xg/ml
R .P.E .(%) Focus type 
II III
Transformation
Incidence
10.0 98.4 4 1 3/40
50.0 92.5 6 - 6/40 p= 0 .13
100.0 90.8 4 - 4/40
200.0 90.2 6 1 6/40
Water 100.0 2 - 2/40
3-MCA 82.7 50 21 31/40
Fig. 4.7 Results of ferrous chloride in the C3H/lOTVfc assay.
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Aluminium Chloride
100
•  R.P.E.
v  Transformation 
Incidence
GQ> I!
4 0  h
20 j -
--------------------- 1______________ I______________ I
10°  10 1 102 103
Concentration /xg/m l
A1C13
/xg/ml
R.P.E.(%) Focus type 
II III
Transformation
Incidence
1.0 80.9 6 4/40
10.0 82.5 2 - 2/40
100.0 92.3 1 - 1/40
500.0 92.1 2 - 2/40
Water 100.0 1 - 1/40
3-MCA 81.8 44 27 28/39
Fig. 4.8 Results of aluminium chloride in the C3H/10TV2 assay.
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100.0 91.2 - - 0/40
500.0 79.9 - - 0/40
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3-MCA 86.5 14 24 25/39
Fig. 4.9 Results of titanium chloride in the ChYillOT'h assay.
6 0
4 0
20
•  R.P.E
v  Transformation 
Incidence
10 10' 10 '
7 0
4.3 Results of metal particles in the C3H/10TV2 assay.
In the metal particle tests, the assays were carried out with the same 
48 hour exposure time as in the metal salt assays. In practice however, it proved 
impossible to remove substantial amounts of the particles after the exposure period 
as they tended to adhere to the cell surfaces despite repeated washing with saline 
(Fig.4.10). In effect then, these results reflect a period of continuous exposure of 
the cells to metal particles during both cytotoxicity and transformation assays, 
particularly at the higher concentration levels. Unfortunately electron microsco­
py facilities were not available to ascertain whether the retained particles were 
truly internalised or simply remained on the cell surface.
Details of the results of metal particles in the C3H/10TVfc assay are 
shown in Appendix D. In each case the result is from one assay for each pure 
metal or alloy.
4.3.1 Cell transformation.
In contrast to the soluble metal salts, metal particles produced no 
significant increases in transformation incidence in any of the assays. In fact, in 
the majority of cases no foci were seen at all. This difference presumably reflects 
the physical form in which the metals were delivered.
4.3.2 Cytotoxicity.
There were, however, differences in toxicity between the various 
metal particles tested. Cobalt particles were most toxic over a range of 0.5 to 10 
/xg/ml. Nickel particles became markedly toxic at 5 /xg/ml and vanadium at 50 
/xg/ml. Chromium particles became noticeably toxic at 100 /xg/ml, but the re­
maining pure metals molybdenum, aluminium and titanium showed marked toxic­
ity only at the highest concentration of 500 /xg/ml. In the case o f iron, the 500
7 1
figlml concentration was lost but it showed little toxicity at 100 ixglml. As might 
be expected, the three alloys stainless steel, CoCr and Ti6A14V showed patterns 
of toxicity which were intermediate between the most and least toxic pure metals. 
Perhaps more surprisingly, CoCr with its large cobalt com ponent appeared 
somewhat less toxic than the other two alloys.
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Fig. 4.10 C3H/10T‘/2 cells after washing with PBS. Part ic les of  
titanium remain adherent to the cells (unstained, x400).
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4.4 Results of human cell assays.
4.4.1 Anchorage independent growth.
Several attempts were made to induce the formation o f colonies of 
human cells in sem i-solid agar medium by known carcinogens. Both human 
synovial fibroblasts and human foreskin cells were used and were treated with N- 
methyl-N'-nitro-N-nitrosoguanidine and 3-methylcholanthrene in separate assays. 
However, although both cell lines grew well under normal growth conditions, no 
anchorage independent colonies arose in response to carcinogen treatment. In 
view of this failure it was not possible to proceed with studies of metal-induced 
transformation.
4.4.2 Cytotoxicity.
Cytotoxicity assays were carried out on human synovial fibroblasts 
(HSF). They were treated at the same concentration levels as C3H/10TV2 cells 
for both metal salts and metal particles. Results o f these assays are shown in 
Appendix E. In each case the result is of one assay.
In general there were no major differences between the results of the 
cytotoxicity tests on human and murine fibroblasts. Metal salts which were toxic 
to C3H/10TV2 cells (CoCl,, N iC l,, N a ,C r0 4, CrCl3 and VOCl2) were equally 
toxic to HSF cells over the same concentration ranges. Salts which were non­
toxic to C3H/10TV2 cells (FeIICl2, Na9M o04, A1C13 and TiCl3) were also non­
toxic to HSF cells. The findings were similar with metal and alloy particles.
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CHAPTER FIVE 
DISCUSSION O F RESULTS
5.1 Study Design.
As stated  in C hapter 1, the aim s o f the study w ere e ssen tia lly  
comparative in nature. The C3H/10T]/2 assay was employed as a screening tool 
to compare the effects of the various metals used in orthopaedic prostheses rather 
than to investigate mechanisms of carcinogenicity or toxicity. Some o f the the 
involved metals have been studied previously in a variety of in vitro systems, 
others have not. To date no previous studies have examined all o f the principal 
constituents o f orthopaedic implants in the same system under the same condi­
tions. The IARC protocol was followed to allow valid comparison with other 
studies as far as possible.
Metals were tested in two physical forms which may arise from in 
vivo corrosion and wear i.e. as soluble ions and solid particles. In the case o f 
chromium, numerous studies have demonstrated differences in activity between 
the trivalent and hexavalent forms (see Patierno et al 1988), therefore chromium 
was tested in both valence states.
In order to evaluate the consistency of the results it was intended to 
perform every assay twice. This was achieved with the metal salt preparations 
and the results appeared to be generally consistent for all the m etals tested. 
Because o f the tim e taken for each assay and the large num ber o f rep licates 
required it was not possible to repeat the metal particle experiments in the time 
available for the study. In view of the uniform lack of effect of the metal particles 
in the transformation studies, it seems unlikely that repeating the assays would 
have yielded further information.
As originally planned, the results of the transformation experiments
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in the human cell assay would have been of great help in the interpretation and 
extrapolation of the mouse cell studies. With the failure of the human cell con­
trols to give valid results, this was not possible. However cytotoxicity assays 
were carried out on human cells with all the metal preparations to allow compari­
son of the two cell lines in that respect.
5.2 Strengths and weaknesses of the C3H/10TV2 transformation assay.
Before considering the results in more detail, some aspects o f the 
C3H/10Ty2 transformation assay require clarification.
As a permanent cell line with well defined growth characteristics 
and requirements, C3H/10T!/2 cells are relatively easily maintained and manipulated. 
Once stained, transformed foci stand out clearly against the background mono­
layer making scoring relatively easy. Used below passage 15, the cells have a 
low spontaneous transformation frequency and the use of 3-m ethylcholanthrene 
allows clear validation that the assay is working. The assay is well established 
and appears to have reasonably good interlaboratory reproducibility (Dunkel et al, 
1988). A number o f other features such as the facility to carry out concomitant 
m utagenicity assays make the line suitable for m echanistic studies o f in vitro  
transformation.
However, when using the assay as a screening tool as in this study, 
a number of potentially restricting factors need to be considered. As a permanent 
cell line C3H/10TV2 cells are not normal but have already acquired some of the fea­
tures of neoplastic transformation such as aneuploidy and im mortalisation while 
retaining some features o f untransform ed cells such as contact inhibition  and 
normal morphology. The in vitro transformation of C3H/10Ty2 cells is therefore a 
measure of the capacity to induce some of the steps in the multistage process of 
carcinogenesis. Secondly, as 50% of type II and 80% of type III foci produce
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tumours in inoculated mice, the induction of foci is often but not always equiva­
lent to the induction of tumorigenicity. Thirdly, a number of studies have shown 
that attempts to quantify transformation by measuring transformation frequency 
(number o f foci per viable cell treated) give results that are highly dependent on 
the initial number of treated cells - transformation frequency tends to decrease 
with increasing numbers of treated cells (Kennedy et al 1980, Huband et al 1985). 
The reason for this is not fully understood at present and this makes it difficult 
to analyse the assay in a quantitative way. Transformation frequency is there­
fore not calculated and the result is given as the transformation incidence, derived 
from the number of foci-containing dishes per total number of treated dishes. The 
significance of the increase in transformation incidence over the negative control 
helps in the interpretation of the results but the assay remains to some extent a 
qualitative study.
Finally, it has been noted already that some batches o f foetal calf 
serum do not support transformation by 3-methylcholanthrene. It seems possible 
then that batches which do support transformation may do so to different extents 
and thus bias the results. In this study, comparison of the results of the batch tests 
with the controls used in the actual assays showed no evidence that any serum 
batch was more likely to give positive results than the others. In addition, the two 
assays carried out for each metal salt were done using different serum batches. It 
is hoped then that any batch related effect was minimised.
5.3 Com parison with previous work.
In common with other work in the field o f metal carcinogenesis, 
previous studies of in vitro transformation by metals have tended to concentrate on 
metals with widespread industrial and occupational exposure, particularly nickel 
and chromium, with somewhat less attention to the other metals o f orthopaedic
77
interest. Metals have been tested in a number of cell systems.
5.3.1 Metal-induced transformation of C3H/10TV2 cells.
A large number o f substances have been tested in the C SH /IO T ^ 
system but relatively few studies have looked specifically at metals.
In an early study Saxholm et al (1981) found that particles of nickel 
subsulphide, a common constituent of nickel ores, induced the formation of type I, 
II and III foci but at a lower frequency than 3-methylcholanthrene.
Patierno et al (1988) investigated the effects o f chrom ium  com ­
pounds and found that insoluble particles of lead chromate produced a low but 
reproducible rate of type III transformation whereas soluble calcium chromate and 
potassium dichromate did not induce transformation. A second study from the 
same laboratory (M iura et al, 1989) found that insoluble nickel subsulphide, 
nickel monosulphide and nickel oxide produced transformation which was predo­
minantly of type II morphology while soluble nickel chloride and nickel sulphate 
gave negative results. In the latter two studies the soluble nickel and chromate 
salts were tested in concentration ranges equivalent to those used in the present 
study and caused similar reductions in plating efficiencies. The results o f the 
transformation studies of soluble and particulate metals in these reports are clearly 
different from those in the present study. The different results with the particles 
can be accounted for by the nature of the particles and is discussed in more detail 
in the next section. The differences in the soluble salt studies may reflect differ­
ent standards in the scoring of transformed foci or may be related to differences in 
the serum used in the culture medium.
Most recently Kowalski et al (1992) reported that addition of sodium 
vanadate to bovine papillomavirus DNA-transfected C3H /10T1/2 cells increased 
the number of transformed foci up to 50-fold suggesting that vanadate may act as
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a tumour promotor, though they did not specify the morphology of the foci pro­
duced.
5.3.2 Metal-induced transformation of BALB/3T3 cells.
The BALB/3T3 C1.A31 transfo rm ation  assay is s im ila r to the 
C3H/10TV2 system in that it uses as its endpoint the formation of transformed 
foci in a monolayer of contact-inhibited mouse embryo fibroblasts. Saffiotti and 
Bertolero (1989) reported that soluble potassium chromate induced dose dependent 
type III transformation of BALB/3T3 cells and that the transformed cells produced 
non-metastatic fibrosarcomata in nude mice. Sabbioni et al (1991) studied the 
effects of soluble vanadium compounds in the same system and found that penta- 
valent vanadium (ammonium vanadate) produced type III transformation whereas 
tetravalent vanadium (vanadyl sulphate) did not cause transformation.
5.3.3 Metal-induced transformation in other rodent cell systems.
Metals have been more extensively studied in the Syrian Hamster 
Embryo (SHE) transformation assay. This system differs from the C 3H /10T1/2 
assay in that individual colonies of exponentially growing cells are examined for 
morphological transformation after a shorter incubation period following treat­
ment.
DiPaulo and Casto (1979) examined a number of metal compounds 
in the SHE system and obtained positive results with nickel sulphate, nickel sub­
sulphide and sodium chromate while ferric oxide, titanium dioxide and aluminium 
chloride did not induce transformation. Costa et al (1978) also found that nickel 
subsulphide and nickel dust induced morphological transformation in SHE cells 
and that nickel subsulphide-transformed cells produced sarcomas in nude mice 
(Costa et al 1979). Costa and Mollenhauer (1980) then showed that the transfor­
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mation of SHE cells by nickel subsulphide was proportional to the uptake o f the 
particles by phagocytosis and found similar effects with particles o f cobalt sul­
phide (Costa et al 1982).
Other studies have examined metals as enhancers or promoters of 
cell transformation. Casto et al (1979) tested a large number o f metal compounds 
for their capacity to enhance viral transformation of SHE cells. Among those 
giving positive results were calcium chromate, cobalt acetate, nickel sulphate and 
ferrous chloride while aluminium chloride and titanium dioxide did not increase 
the rate of transformation. Similarly, Rivedal and Sanner (1981) demonstrated 
that nickel sulphate and potassium chromate promoted SHE cell transformation 
initiated by benzo[a]pyrene and more recently Rivedal et al (1990) found a similar 
effect with various vanadium compounds.
Baby H am ster Kidney (BHK21) cells have been used to study 
anchorage independent growth. Using this method Fradkin et al (1975) obtained 
positive results with calcium chrom ate. Sim ilarly, Hansen and Stern (1982) 
induced transformation with a number of nickel preparations.
5.3.4 M etal-induced transform ation in hum an cells.
Attempts to develop transformation assays in human cells based on 
focus formation as in the rodent cell assays have generally been unsuccessful. 
However Biedermann and Landolph (1987, 1990) developed an assay in which 
anchorage independent growth of diploid human fibroblasts was induced by a 
number of nickel and chromium salts including lead chromate, potassium dichro- 
m ate, nickel subsulphide and nickel sulphate. No other studies o f this type 
appear to have been done and in the present study the method was not successful.
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5.3.5 Summary.
No previous investigations of in vitro transformation by metals have 
specifically examined metals o f orthopaedic interest with the aim o f comparing 
their relative risks. Although some of the metals, particularly nickel and chromi­
um, have been tested a number of times in various studies, others have received 
little attention and direct comparisons are difficult to make owing to variations in 
the assay methods and the preparations used.
Only nickel and chromium have previously been tested in the stan­
dard C3H/10TV2 assay. These studies produced conflicting results with the 
present study in that soluble nickel and chromate salts did not induce transforma­
tion. However insoluble nickel and chromate salts did produce positive results.
Soluble nickel and chromate salts have repeatedly yielded positive 
results in the other assay systems. Of the other metals which induced transforma­
tion in this study namely cobalt, trivalent chromium and molybdenum, only cobalt 
appears to have been tested previously, producing positive results in the SHE 
assay.
Titanium , aluminium, iron and tetravalent vanadium did not cause 
transformation in the present study. Of these titanium, aluminium and tetravalent 
vanadium have also produced negative results in other assays. One study suggests 
that ferrous chloride may enhance transform ation o f SHE cells and studies of 
vanadium suggest it has transforming potential in its pentavalent form.
The results in this study are therefore in broad agreem ent with 
previous work on metal-induced transformation, bearing in mind that with the 
exceptions o f nickel and chromium, previous studies are somewhat limited in 
number.
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5.4 Effect of the physical form of metals.
The importance of the physical form in which the metals are presen­
ted is clearly shown in the results of the metal particle experiments. Several of the 
metals tested as soluble salts produced transformation. When tested as metallic 
particles they did not do so but still showed evidence of toxicity. These differ­
ences may be related to a number of factors.
5.4.1 Phagocytosis and transformation.
Costa and Mollenhauer (1980) found that particles of nickel subsul­
phide were taken up by vacuolation in SHE cells and were more potent transform­
ing agents than soluble nickel chloride. Further studies (Costa et al 1981, Costa 
et al 1982) indicated that the cellular uptake and consequent transforming potency 
of particulate nickel compounds was related to their physical structure. Particles 
o f crystalline nickel subsulphide were actively phagocytised and induced trans­
formation whereas particles of amorphous nickel sulphide and o f metallic nickel 
were not taken up and did not cause transformation. More recently, Patiemo et al 
(1988) related the transformation of C3H/10TV& cells by insoluble particles of 
lead chromate to internalisation of the lead chromate particles as shown by elec­
tron microscopy. The authors suggested that this may be the result of prolonged 
intracellular release of metals by slow dissolution or due to more complex and at 
present unrecognised intracellular mechanisms. These observations suggest that 
in the present study, although the metal particles were seen to be in close associa­
tion with the cells, they were not truly internalised.
5.4.2 Solubility of metals.
The effects of differences in the solubilty of metal particles on cells 
in culture was demonstrated previously by Rae (1981). In a study examining the
82
toxicity of metals used in orthopaedic implants, he found that particles of cobalt 
and vanadium were toxic to cells in culture whereas particles o f nickel, chromi­
um, molybdenum, titanium and aluminium were not. Measurements o f the levels 
of soluble metals in the culture medium during the incubation period revealed that 
only cobalt, vanadium and, to a lesser extent, nickel particles produced detectable 
amounts of soluble metal. It was concluded that the toxicity of the metal particles 
was related to their solubility. Similar effects were seen in the present study with 
cobalt, nickel and vanadium particles producing toxicity while the other metal 
particles were relatively non toxic.
5.4.3 Physical effects of metal particles.
It will be noted that in the cases of cobalt and nickel particles, toxi­
city occurred at around the same dose levels as with the soluble salts. As the 
metal particles did not completely dissolve in the culture medium - indeed they 
remained clearly visible throughout the incubation period - the actual concentra­
tion of soluble metal in the particle experiments would have been much lower than 
in the equivalent metal salt assays. Rae (1978) also showed that some metal 
particles, notably cobalt, nickel and Co-Cr alloy, caused direct damage to cell 
membranes. It therefore seems probable that the toxicity seen with some of the 
metal particles was a result o f both the release of soluble metal ions and direct 
physical damage to the cells.
Equally, visible amounts of metal particles remained in the culture 
dishes during the transformation assays and presumably gave rise to soluble metal 
ions throughout the incubation period. However, the medium was changed at 
regular intervals so it is unlikely that there was any significant accumulation of 
soluble metal after the initial exposure period.
83
5.5 The relative risks of orthopaedic metals as measured by this study.
One of the primary aims of this study was to assess the relative risks 
of the main orthopaedic alloys and of their constituent metals in terms of potential 
carcinogenicity and toxicity. The design of the transformation assays allows both 
these aspects to be tested and also allows comparison with a known potent carci­
nogen. The relative plating efficiency gives a quantitative measure of cytotoxicity 
allowing direct comparison of the metals. As stated previously, the measurement 
of transformation incidence does does not give a truly quantitative value. How­
ever, a semi-quantitative comparison may be made from the dose levels at which 
transformation occurs and a further qualitative comparison may be made from the 
focus morphology.
5.5.1 Soluble metal salts.
Nine metal salts were tested in the C3H/10TV2 cytotoxicity/trans­
formation assay.
Cobalt chloride, nickel chloride, chromium chloride, and sodium 
chromate demonstrated both toxic and neoplastic effects. All four compounds 
demonstrated dose related toxic effects and a trend towards dose related neoplas­
tic transformation. For these metals, there appeared to be a correlation between 
toxicity and transformation with transformation increasing with toxicity (Fig. 5.1). 
In terms o f the concentrations at which toxicity and neoplastic transformation 
occurred, sodium chromate was the most potent agent and chromium chloride the 
least potent, with cobalt chloride and nickel chloride intermediate. None of these 
metals produced transformation to the same extent as 3-methylcholanthrene and all 
of the transformation foci were of the less "aggressive" type II morphology.
At the other extreme, three compounds, ferrous chloride, aluminium 
chloride and titanium chloride were neither toxic nor did they cause significant in-
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Fig. 5.1 Transformation incidence (TI) and relative plating efficiency (RPE) for 
those metal salts which were both toxic and transforming.
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creases in transformation incidence. Titanium chloride produced no transforma­
tion foci at any concentration.
The remaining two compounds however, did not demonstrate this 
relationship between toxicity and transformation. Sodium molybdate showed very 
little evidence of toxicity but did produce significant transformation, though not in 
a dose related fashion, whereas vanadyl chloride was highly toxic but did not 
cause transformation.
5.5.2 Particulate metals and alloys.
Eight particulate metals and three particulate alloys were tested in 
the C3H/10TV2 assay.
When tested in particulate form, none of the metals or alloys pro­
duced cellular transformation. Cobalt, nickel and vanadium were markedly toxic, 
while chromium, iron, molybdenum, aluminium and titanium were relatively non­
toxic. The three alloys, stainless steel, CoCr and Ti6A14V showed intermediate 
toxicity.
5.5.3 Summary.
This study has shown that some of the metals used in orthopaedic 
prostheses are capable of inducing cellular transformation in vitro . The metals 
were weaker transforming agents than the control, 3-methylcholanthrene, both in 
terms of the incidence of transformation and the degree to which the cells were 
transformed. Transformation occurred with soluble metal salts but not with metal 
particles, possibly reflecting differences in the intracellular availability o f free 
metal ions. In general there appeared to be a relationship between toxicity and 
carcinogenicity in that most of the metals which were toxic produced transforma­
tion and those which were not toxic did not transform, though two metals did not
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display this correlation.
It is clear that under the conditions of this study o f the metals used 
in orthopaedic prostheses some are potentially m ore hazardous than others, 
depending to some extent on the physical form in which the metals are presented. 
The greatest risks, both for toxicity and carcinogenicity, are associated with co­
balt, chrom ium  and nickel and the least with iron, alum inium  and titanium . 
Vanadium is potentially harm ful because o f its cytotoxicity  and molybdenum 
showed evidence of possible carcinogenicity.
On this basis, the safest alloy in current use would appear to be 
titanium-aluminium-vanadium. None of the constituent metals caused transforma­
tion and only vanadium, a minor element of the alloy, was toxic. Both stainless 
steel and cobalt-chrom ium  alloy contain appreciable am ounts o f those metals 
which showed evidence both of transforming ability and toxicity.
These observations are necessarily based on the results o f experi­
ments on rodent fibroblasts. The results of the human cell experiments indicate 
that these conclusions hold true for human cells as far as toxicity is concerned but 
it was not possible to confirm the transformation findings in human cells.
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5.6 Reasons for the failure of the human cell transformation assay.
5.6.1 General difficulties with human cells in culture.
Although there are several well documented assays for the carcino­
gen-induced transformation of rodent cells in culture, in vitro transform ation of 
normal human cells to malignant behaviour has proved to be more difficult. A 
number o f authors have reviewed these difficulties in detail (DiPaulo 1983, Ga- 
brielson and Harris 1985, Milo and Casto 1986, Harris 1987, M cCorm ick and 
Maher 1988). All are agreed that the problems in transforming human cells stem 
from their inherent stability in culture. Rodent cell cultures often give rise to cell 
lines with infinite lifespans and abnormal karyotypes and it is in these abnormal 
populations that transformation to malignant behaviour may be induced. In con­
trast, the spontaneous appearance of such characteristics as infinite lifespan and 
karyotypic abnormalities rarely, if ever, occurs in cultures of diploid human cells. 
This difference is probably a reflection not only of the greater species susceptibil­
ity o f the rodent cells, but also of the inbred nature of the strains o f laboratory 
animals from which the cells are derived. Cultured human cells are of necessity 
much more heterogenous in origin.
Because of this difficulty, a reproducible assay for the m alignant 
transformation of human cells has yet to be developed. There have been reports 
o f the transform ation o f human cells (Kakunaga 1978), but this has not been 
reproduced in other laboratories. Indeed, a later study indicated that these results 
were due to contamination of the assay by fibrosarcoma cells and concluded that 
no one had yet succeeded in producing malignantly transformed cells by carcino­
gen treatment of normal human fibroblasts (McCormick and Maher 1988).
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5.6.2 Factors relevant to this study.
Studies of carcinogenicity in human cell cultures have therefore 
concentrated on the induction of "transformation-like" changes which are thought 
to represent steps in the multistage process of malignant change (Harris 1987). 
Conversion to anchorage independent growth has been one o f the most widely 
used endpoints and the study of Biedermann and Landolph (1987) was the first to 
report positive results with metals using this endpoint. In the present study, valid 
results could not be obtained and the following observations may help explain this.
The assay for anchorage independent growth is technically more 
difficult to perform than the more straightforward growth of monolayer cultures 
and it is possible that more experience with the technique would have yielded 
better results.
It was originally hoped to perform the assay using human synovial 
fibroblasts as it was thought they would be more relevant in a study related to 
orthopaedic implants. However, the great majority of previous studies on human 
fibroblasts have used neonatal foreskin cells and it seems likely that synovial cells 
from a nine year old donor are not suitable for this type of study.
Tejwani et al (1982) reported that only early passage neonatal fore­
skin fibroblasts can be successfully transformed to anchorage independence. The 
foreskin cells used in the present study were obtained at passage 9 and used at 
passage eleven onwards. Biedermann and Landolph (1987) whose protocol was 
followed do not state precisely at which passage number cells were used but as 
they were grown de novo from foreskin explants it is likely that they were earlier 
passage cells than those used in this study.
A second factor known to influence the assay is the use of cell cycle 
synchronisation prior to carcinogen exposure. Zim m erm an and L ittle  (1981) 
showed that pre-treatment synchronisation by use of amino acid deficient medium
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increased the frequency of transformation compared with treatment of cells used 
at confluence. Similarly, Silinskas et al (1981) showed that the use of synchro­
nised cells produced an increase in transformation of 25 % over that obtained with 
randomly dividing cells.
It is possible that with greater experience of the assay and the use of 
early passage primary cultures combined with pre-treatment cell synchronisation, 
results in the present study could have been improved. Unfortunately restrictions 
on the time available for the study meant that these avenues could not be explored 
further.
90
CHAPTER SIX 
GENERAL DISCUSSION
6.1 Overview
The history of implant surgery is one of continual development and 
refinement with the principles o f biomechanics and biocompatibilty progressing 
hand in hand. As some problems are solved others emerge to be investigated and 
dealt with in the quest for the perfect material. Past successes mean that millions 
of patients worldwide now enjoy the undisputed benefits of metallic implants in 
fracture fixation and joint replacement surgery. However the question of implant- 
associated malignancy reminds us of the need for constant vigilance and ongoing 
assessment.
The background review  o f this thesis clearly  dem onstrates the 
multi-disciplinary nature of the study of biocompatibility. A comprehensive inves­
tigation of implant-related carcinogenesis would include many interrelated aspects 
and is beyond the scope of any single piece of work. This study confined itself to 
one o f these aspects, the role of metals as chemical toxins and carcinogens. It 
examined and compared the principal constituents of the standard implant alloys in 
a single cell culture system designed to assess toxicity and carcinogenic potential. 
Some metals induced cell transformation and others did not. While this does not 
prove that metal implants cause cancer, the results add to our knowledge of metal 
carcinogenesis and provide a way of grading the relative risks of the currently 
used alloys. The greatest risks were associated with cobalt, chromium and nickel 
and the least with iron, aluminium and titanium. These findings are in broad 
agreement with the results of previous work including epidemiological studies of 
human exposure, experimental animal bioassays and in vitro cell transformation 
studies. On this basis the safest alloy in terms of toxicity and potential carcinoge­
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nicity would appear to be Ti6A14V. The relevance of this work to clinical prac­
tice requires consideration of a number of other factors.
6.2 Relevance to the in vivo situation.
C losed cell cu ltu re  system s do not alw ays re fle c t the com plex 
mechanisms of the intact organism. Most of the metals released from implants 
play biological roles as trace elements and it is likely that homeostatic mechanisms 
exist for their uptake, distribution and excretion. However great increases over 
the normal trace levels may overwhelm these mechanisms and lead to sustained 
high systemic levels of metal as reflected in the high blood levels found in some 
studies. Similarly, the cells o f the lymphoreticular system act as scavengers in 
removing particulate debris but it is clear that when wear is excessive there are 
limits to this process and that local levels remain high. Thus when regulatory 
mechanisms fail, the situation in vivo may be similar to that created in vitro.
Clearly, the results of observations on rodent cells must be inter­
preted with caution in considering the human recipient. It was not possible to 
conduct transformation experiments on human cells but the findings in the cytotox­
icity tests indicate that, at least as general toxins, the tested metals behave similar­
ly in human and mouse cells.
Studies on patients with join t replacements show conclusively that 
metals are released from all of the alloys in use. However, little is known of the 
precise physical form in which they are released or of their interactions with 
homeostatic mechanisms. It is generally accepted that metals are biologically 
most active in the soluble ionic form. Histological examination of periprosthetic 
tissue frequently shows the presence of particles but measurements of metal levels 
in such tissues give only a gross weight-for-weight figure with no indication of the 
concentration of soluble ions. Increased blood levels of metals are seen in cases
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of prosthetic wear but it is not known w hether the metals in these cases are 
predom inantly  freely dissolved or protein bound. Such considerations create 
difficulties in assessing the significance of metal release in vivo. However, it 
seems likely that in clinical situations where wear occurs, the bulk o f released 
metal exists as solid particles which then give rise to the release o f soluble ionic 
forms. When wear has not occurred soluble metals are released more slowly by 
pure corrosion from the surface of the implant.
In the present in vitro study cell transformation was only seen with 
soluble metals. The metal concentrations used in this study were far greater than 
those reported in body fluids from patients. This must be weighed against the 
considerably longer exposure time which may occur in vivo.
Particulate metals and alloys did not cause cell transformation in this 
study. In other cell culture studies the transforming potency of particles of metal 
compounds has been related to their cellular uptake. It is clear from histological 
studies that in vivo , large numbers of wear particles accumulate intracellularly. 
This may give rise to prolonged intracellular release of metal ions and it is there­
fore conceivable that metallic wear debris may actually be more dangerous in vivo 
than suggested by the cell culture system used in this study.
There is also uncertainty as to the nature of the metallic wear parti­
cles seen around implants. Although measurements clearly show that the particles 
contain metals it is possible, particularly in the case o f titanium, that they arise 
from wear of the passivated surface o f the prosthesis and therefore consist of 
metal oxides and hydroxides rather than pure metals. The significance o f this 
difference in terms of potential carcinogenicity is not known.
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6.3 Clinical implications.
The overall risks of implanted metals depends on the outcome of 
complex physical and biological processes, many of which are still poorly under­
stood. At present the evidence for implant-induced cancer in patients remains 
scanty and somewhat controversial. Conversely the benefits to patients are indis­
putable. H ow ever there is a growing body o f evidence that some metals are 
carcinogenic in certain circumstances. This study indicates that of the alloys 
used in orthopaedic prostheses, some are potentially more dangerous than others 
in this respect, the safest being titanium alloy. Given that it has so far proved 
impossible to completely prevent the release of metal from implants it would seem 
reasonable to direct future developments toward greater use of titanium alloys in 
permanent implants. Wear of the currently used Ti6A14V alloy is a problem 
however and a more wear resistant titanium alloy is needed. The application of a 
wear resistant coating is an alternative approach to the problem. Early studies of 
a very hard diamond-like carbon polymer indicate satisfactory biocompatibility 
(Thomson et al 1991), but its wear resistance in vivo remains to be demonstrated. 
As long as wear and metal release continue to be a problem , efforts should be 
made to minimise tissue burdening by undertaking revision of loose prostheses as 
early as possible with due attention given to other clinical considerations.
Patients with permanent joint replacements tend to be from the older 
age groups with consequently shorter life expectancy. H ow ever many young 
patients receive fracture fixation devices which may then rem ain in place for 
several decades. While metal release from static devices is low, with the prospect 
of such prolonged exposure it would seem prudent to remove these devices in 
young patients after fracture healing has occurred. Metal removal is not always a 
straightforward procedure and should be weighed against the potential risks but 
should be possible in most cases. This policy has obvious cost implications in a
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financially constrained health service. The development of biodegradable fixation 
devices may in future reduce the need for metal removal.
6.4 Recommendations for future work.
In vitro cell transformation studies have become valuable tools for 
the screening of potential carcinogens and in the study o f carcinogenic mecha­
nisms. They have a number of limitations but hopefully will become increasingly 
sophisticated as the understanding of cellular mechanisms improves. The devel­
opment o f reliable in vitro human cell transformation systems would greatly in­
crease their value. Further attempts to produce metal-induced anchorage inde­
pendent growth in human cells along the lines described in chapter 5 could pro­
duce very useful comparisons with the results already achieved and should be 
pursued. However, early passage neonatal foreskin cells are less easy to obtain in 
the United Kingdom than in the United States where the method was developed 
and where elective circumcision is more common practice. It is possible that a 
similar assay using umbilical cord cells may be more successful.
In recent years it has been discovered that in some tum ours the 
process of carcinogenesis is associated with the activation of specific genes called 
oncogenes. Evidence o f oncogene activation has been found in transform ed 
C3H/10TV* cells (Billings et al 1987). It would be of great value to apply this 
technique to metal-transformed cells to aid in the confirmation and quantification 
of transformation.
The present study was lim ited to testing metal salts and metal or 
alloy particles. It seems likely that the particulate debris produced in vivo is at 
least partly composed of metal oxides and hydroxides. Since this and other stu­
dies show that the physical form of the metal is significant, it is im portant to 
conduct further studies on metal oxide/hydroxide complexes.
The study of molecular biology has made great strides in the under­
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standing of carcinogenic mechanisms. Historically, the discovery of carcinogenic 
agents and the assessm ent o f exposure risk owes much to epidem iological re ­
search. To date only two such studies have exam ined the question o f m etal 
implant-associated cancer and clearly more such studies are needed. Finally, it is 
im portant that orthopaedic surgeons remain aware o f the possible biological ef­
fects o f their treatment and continue to report occurrences o f implant-associated 
tumours.
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Appendix A. Batch testing and validation studies.
1. Plating efficiencies of serum batches.
Batch Plating Efficiency Population
Doubling Time
NBL Batch 19827 50.4% 13 hrs
Imperial Batch 960585 50.4% 12 hrs
Gibco Batch 06G9982Y 43.7% 13 hrs
SeraLab Batch 801053 51.9% 14 hrs
2. Batch transformation assays.
Batch Focus type 
II III
Transformation
Incidence
NBL 19827
3-MCA 2.5 fAg/ml 
DMSOO.5%
16 12/20
0/20
Imperial 960585
3-MCA 2.5 /xg/ml 
DMSO 0.5%
10 14/20
0/20
Gibco 06G9982Y
3-MCA 2.5 /zg/ml 
DMSO 0.5%
21 14/20
1/20
SeraLab 801053
3-MCA 2.5 Acg/ml 
DMSO 0.5%
30 18 18/20
0/20
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3. Growth curves for serum batches.
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1 2 3
Appendix B. Results of metal salt cytotoxicity assays.
Cobalt Chloride
Assay 1 Assay 2
Concentration
Gig/ml) P.E.(%) R.P.E.(%) P.E.(%) R.P.E.(%)
0 20.8 100 19.9 100
0.1 19.2 92.3 13.0 65.3
1.0 12.4 59.6 7.2 36.2
5.0 0.6 2.9 1.4 7.0
10.0 0.4 1.9 0 0
20.0 0.1 0.5 0 0
Nickel Chloride
Concentration
(Mg/ml)
Assay 1 
P.E.(%) R.P.E.(%)
Assay 2 
P.E.(%) R.P.E.(%)
0 21.4 100 19.9 100
1.0 22.5 105 20.7 104
10.0 9.9 46.3 7.9 39.7
20.0 1.4 6.5 1.4 7.0
40.0 0.1 0.5 0 0
60.0 0 0 0.2 1
Chromium Chloride
Concentration
0*g/ml)
Assay 1 
P.E.(%) R.P.E.(%)
Assay 2 
P.E.(%) R.P.E.(%)
0 22.2 100 19.9 100
300.0 24.2 109 19.9 100
600.0 21.7 97.7 9.2 46.2
900.0 13.2 59.5 9.6 48.2
1200.0 0 0 14.2 71.3
1 24
Sodium Chromate
Assay 1 Assay 2
Concentration
(jug/ml) P.E.(%) R.P.E.(%) P.E.(%) R.P.E.(% )
0 18.9 100 19.9 100
0.005 18.7 98.9 17.6 88.4
0.01 15.2 80.4 21.1 106.0
0.05 16.1 85.2 10.7 53.7
0.1 9.2 48.7 8.5 42.7
0.5 0.1 0.5 0 0
Ferrous Chloride
Concentration 
0*g/ml)
Assay 1 
P.E.(%) R.P.E.(%)
Assay 2 
P.E.(%) R.P.E.(% )
0 23.0 100 34.9 100
10.0 21.9 95.2 35.5 101.7
50.0 23.6 102.0 29.0 83.1
100.0 21.2 92.2 31.2 89.5
200.0 20.6 89.6 31.7 90.8
Sodium Molybdate
Concentration
(Mg/ml)
Assay 1 
P.E.(%) R.P.E.(%)
Assay 2 
P.E.(%) R.P.E.(% )
0 33.5 100 36.5 100
1.0 35.5 106 34.4 94.2
10.0 32.7 97.6 35.1 96.2
100.0 32.7 97.6 35.6 97.6
500.0 31.9 95.2 39.9 109.2
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Vanadyl Chloride
Assay 1 Assay 2
Concentration
Oug/ml) P.E.(%) R.P.E.(%) P.E.(%) R.P.E.(%)
0 21.0 100 36.5 100
0.1 16.7 79.5 35.1 96.2
0.5 10.6 50.5 20.1 55.1
1.0 8.6 40.9 10.9 29.9
5.0 0 0 0 0
Aluminium Chloride
Concentration
(jug/ml)
Assay 1 
P.E.(%) R .PE .(% )
Assay 2 
P.E.(%) R.P.E.(%)
0 33.5 100 36.5 100
1.0 26.6 79.4 30.1 82.5
10.0 27.2 81.2 30.6 83.9
100.0 31.0 92.5 33.6 92.1
500.0 30.6 91.3 33.9 92.9
Titanium Chloride
Concentration
Oug/ml)
Assay 1 
P.E.(%) R .PE .(% )
Assay 2 
P.E.(%) R.P.E.(%)
0 36.5 100 34.9 100
10.0 28.9 79.2 35.4 101.4
50.0 27.9 76.4 31.0 88.8
100.0 30.9 84.7 34.1 97.8
500.0 
* lost to infection
* 27.9 79.9
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Appendix C. Results of metal salt transformation assays.
Cobalt Chloride Assay 1
Concentration
0*g/ml)
Focus type 
II III
Total
foci
Transformation
Incidence
0.1 1 1 1/20
1.0 5 5 5/20
5.0 5 5 5/20
10.0 7 - 7 6/20
20.0 11 11 7/20
water 1 1 1/20
3-3-MCA 2.5/ig/ml 44 7 51 16/20
Cobalt Chloride Assay 2
Concentration Focus type Total Transformation
foci Incidence
(Mg/ml) II III
0.1 1 1 1/20
1.0 - - 0/20
5.0 6 6 6/20
10.0 6 6 6/19*
20.0 6 6 6/20
water _ 0/20
3-MCA 2.5jug/ml 36 18 54 18/20
* one well lost to infection
Nickel Chloride Assay 1
Concentration Focus type Total Transformation
foci Incidence
(fig/ml) II III
1.0 1 1 1/20
10.0 5 5 5/20
20.0 1 1 1/20
40.0 6 6 4/20
60.0 1 1 1/20
water 1 1 1/20
3-MCA 2.5/^g/ml 44 7 51 16/20
12 7
Nickel Chloride Assay 2
Concentration 
(jig/ml)
Focus type 
II III
Total
foci
Transformation
Incidence
1.0 0/20
10.0 4 - 4 3/20
20.0 14 - 14 9/20
40.0 2 - 2 2/20
60.0 7 - 7 5/20
water _ _ 0/20
3-MCA 2.5ptg/ml 36 18 54 18/20
Chromium Chloride Assay 1 
Concentration Focus type 
G*g/ml) II III
Total
foci
Transformation
Incidence
300.0 5 5 5/20
600.0 1 - 1 1/20
900.0 4 - 4 4/20
1200.0* 13 2 15 8/20
water 1 _ 1 1/20
3-MCA 2.5^tg/ml 44 7 51 16/20
* extensive detachment of monolayer 
with intact monolayers.
Chromium Chloride Assay 2
in 10 wells,foci counted in remaining wells
Concentration 
Q a g/ml)
Focus type
II III
Total
foci
Transformation
Incidence
300.0 0/20
600.0 1 - 1 1/20
900.0 - - - 0/20
1200.0* - - - 0/20
water _ _ _ 0/20
3-MCA 2.5/xg/ml 36 18 54 18/20
* extensive detachment of monolayer 
in remaining areas but no true foci.
in ;all wells, patches of increased cell density
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Sodium Chromate Assay 1
Concentration 
(fig/ml)
Focus type 
II III
Total
foci
Transformation
Incidence
0.005 1 1 1/20
0.01 2 - 2 1/20
0.05 - - - 0/20
0.1 3 - 3 3/16*
0.5 5 - 5 4/16*
water 1 _ 1 1/20
3-MCA 2.5jig/ml 44 7 51 16/20
* four wells lost to infection
Sodium Chromate Assay 2 
Concentration Focus type 
(/zg/ml) II III
Total
foci
Transformation
Incidence
0.005 0/20
0.01 - - - 0/20
0.05 - - - 0/20
0.1 - - - 0/20
0.5 7 - 7 6/20
water _ _ « 0/20
3-MCA 2.5jiig/ml 36 18 54 18/20
Ferrous Chloride Assay 1 
Concentration Focus type 
Qig/ml) II III
Total
foci
Transformation
Incidence
10.0 4 1 5 3/20
50.0 - - - 0/20
100.0 2 - 2 2/20
200.0 - 1 1 1/20
water 1 _ 1 1/20
3-MCA 2.5^g/m l 44 7 51 16/20
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Ferrous Chloride Assay 2
Concentration 
(Mg/ml)
Focus type 
II III
Total
foci
Transformation
Incidence
10.0 0/20
50.0 6 - 6 6/20
100.0 2 - 2 2/20
200.0 6 - 6 5/20
water 1 _ 1 1/20
3-MCA 2.5 jig/ml 6 15 21 15/20
Sodium Molybdate Assay 1 
Concentration Focus type 
(/xg/ml) II III
Total
foci
Transformation
Incidence
1.0 5 5 5/20
10.0 8 3 11 9/20
100.0 2 - 2 2/20
500.0 3 - 3 3/20
water _ _ _ 0/20
3-MCA 2.5)Ug/ml 36 18 54 18/20
Sodium Molybdate Assay 2 
Concentration Focus type 
g/ml) II III
Total
foci
Transformation
Incidence
1.0 1 1 1/20
10.0 - - - 0/20
100.0 - - - 0/20
500.0 1 - 1 1/20
water 1 _ 1 1/20
3-MCA 2.5 jug/ml
. . •
8 9 17 10/19*
* one well lost to infection
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Vanadyl Chloride Assay 1
Concentration
(/xg/ml)
Focus type 
II III
Total
foci
Transformation
Incidence
0.1 1 1 1/20
0.5 - - - 0/20
1.0 - - - 0/20
5.0 - - - 0/20
water 1 _ 1 1/20
3-MCA 2.5/ug/ml 44 7 51 16/20
Vanadyl Chloride Assay 2 
Concentration Focus type 
(fig/ml) II III
Total
foci
Transformation
Incidence
0.1 2 2 2/16*
0.5 - - - 0/20
1.0 - - - 0/20
5.0 - - - 0/20
water 1 _ 1 1/20
3-MCA 2.5 (ig/m\ 8 9 17 10/19**
* four wells lost to infection
** one well lost to infection
Aluminium Chloride Assay 1 
Concentration Focus type 
(fig/ml) II III
Total
foci
Transformation
Incidence
1.0 6 6 4/20
10.0 1 - 1 1/20
100.0 1 - 1 1/20
500.0 2 - 2 2/20
water _ _ _ 0/20
3-MCA 2.5/zg/ml 36 18 54 18/20
1 3 1
Aluminium Chloride Assay 2
Concentration 
G*g/ml)
Focus type 
II III
Total
foci
Transformation
Incidence
1.0 0/20
10.0 1 - 1 1/20
100.0 - - - 0/20
500.0 - - - 0/20
water 1 _ 1 1/20
3-MCA 2.5 ^g/m l 8 9 17 TO/19*
* one well lost to infection
Titanium Chloride Assay 1 
Concentration Focus type 
(/xg/ml) II III
Total
foci
Transformation
Incidence
10.0 0/20
50.0 - - - 0/20
100.0 - - - 0/20
500.0 - - - 0/20
water 1 _ 1 1/20
3-MCA 2.5 /xg/ml 8 9 17 10/19*
* one well lost to infection
Titanium Chloride Assay 2 
Concentration Focus type 
(/xg/ml) II III
Total
foci
Transformation
Incidence
10.0 0/20
50.0 - - - 0/20
100.0 - - - 0/20
500.0 - - - 0/20
water 1 _ 1 1/20
3-MCA 2.5 /xg/ml 6 15 21 15/20
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Appendix D. Results of metal particle cytotoxicity/transformation assays. 
Cobalt Particles
Concentration R.P.E.(%) Focus type Transformation
Incidence
/Kg/ml II III
0.5 34.8 0/20
1.0 29.3 - 0/20
5.0 2.5 2 2/20
10.0 0 - 0/20
water 100 1 1/20
3-MCA - 6 15 15/20
Nickel Particles
Concentration R.P.E.(%) Focus type Transformation
Incidence
Mg/ml II III
1.0 71.2 0/20
5.0 38.3 - 0/20
10.0 25.8 - 0/20
50.0 8.6 - 0/20
100.0 0.7 - 0/20
water 100 1 1/20
3-MCA - 8 9 10/19*
* one well lost to infection
Chromium Particles
Concentration R.P.E.(%) Focus type Transformation
Incidence
Mg/ml II III
5.0 78.7 0/20
10.0 88.0 - 0/16
50.0 89.2 - 0/16
100.0 38.8 - 0/20
500.0 17.8 - 0/20
water 100 1 1/20
3-MCA
*1* h i
8 9 10/19*
* one well lost to infection
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Iron Particles 
Concentration 
/xg/ml
R.P.E.(%) Focus type 
II III
Transformation
Incidence
5.0 99.9 1 1/20
10.0 98.8 1 1/20
50.0 89.9 - 0/20
100.0 93.8 - 0/20
water 100 1 1/20
3-MCA - 8 9 10/19*
* one well lost to infection
Molybdenum Particles
Concentration R.P.E.(%) Focus type Transformation
Incidence
/xg/ml II III
5.0 107.4 1 1/20
10.0 106.4 - 0/20
50.0 102.8 - 0/20
100.0 98.5 - 0/20
500.0 28.7 - 0/20
water 100 1 1/20
3-MCA - 6 15 15/20
Titanium Particles
Concentration R.P.E.(%) Focus type Transformation
Incidence
/xg/ml II III
5.0 95.3 1 1/20
10.0 97.8 - 0/20
50.0 59.4 1 1/20
100.0 60.9 - 0/20
500.0 26.5 - 0/17*
water 100 1 1/20
3-MCA - 8 9 10/19**
* three wells lost to infection
** one well lost to infection
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Vanadium Particles
Concentration R.P.E.(%) Focus type Transformation
Incidence
fig/ml II III
5.0 91.3 0/20
10.0 65.2 - 0/16
50.0 4.0 - 0/20*
100.0 0.0 - 0/20**
water 100 1 1/20
3-MCA _ ■ 6 15 15/20
* incomplete monolayer at end of transformation assay
** no viable cells at end of transformation assay
Aluminium Particles
Concentration R.P.E.(%) Focus type Transformation
Incidence
ixg/m 1 II III
5.0 93.7 0/20
10.0 88.0 - 0/20
50.0 69.0 - 0 /2 0
100.0 76.0 - 0/20
500.0 0.0 - 0.20
water 100 1 1/20
3-MCA - 6 15 15/20
Stainless Steel
Concentration R.P.E.(%) Focus type Transformation
Incidence
iug/ml II III
5.0 82.1 1 1/20
10.0 81.8 - 0/20
50.0 54.8 - 0/20
100.0 21.6 - 0/20 .
500.0 0.0 - 0/19*
water 100 1 1/20
3-MCA - 8 9 10/19*
* one well lost to infection
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Cobalt-chromium alloy
Concentration R.P.E.(%) Focus type
pg/m l II III
Transformation
Incidence
5.0 79.2 - - 0/20
10.0 93.0 - - 0/20
50.0 79.6 - - 0/20
100.0 63.4 - - 0/20
500.0 10.6 - - 0/20
water 100 1 - 1/20
3-MCA - 6 15 15/20
Ti6A14V Alloy
Concentration R.P.E.(%) Focus type Transformation
Incidence
Hg/ml II III
5.0 97.2 - - 0/19*
10.0 94.9 - - 0/20
50.0 46.7 - - 0/20
100.0 15.7 - - 0/20
500.0 0.0 - - 0/20
water 100 1 _ 1/20
3-MCA - 6 15 15/20
* one well lost to infection
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Appendix E. Results of cytotoxicity assays with human synovial fibroblasts.
I. Metal salts
Cobalt Chloride
Concentration
(iug/ml)
P.E.(%) R.P.E.(%)
0.0 28.6 100
0.1 26.6 93.1
1.0 20.2 70.8
5.0 11.6 40.6
10.0 10.1 35.4
20.0 5.1 17.9
Nickel Chloride
Concentration 
G*g/ml)
P.E.(%) R.P.E.(%)
0.0 26.8 100
1.0 28.6 106.8
10.0 16.0 59.7
20.0 4.0 14.9
40.0 0 0
60.0 0 0
Chromium Chloride
Concentration
frig/ml)
P.E.(%) R.P.E.(%)
0.0 29.8 100
300.0 28.2 97.8
600.0 21.6 72.6
900.0 24.2 81.4
1200.0 16.1 54.1
1 3 7
Sodium Chromate
Concentration
Gig/ml)
P.E.(%) R.P.E.(%)
0.0 28.4 100
0.005 28.5 100
0.01 30.9 108.7
0.05 22.2 78.3
0.1 17.4 61.2
0.5 0 0
Ferrous Chloride
Concentration P.E.(%) R.P.E.(%)
(Mg/ml)
0.0 27.8 100
10.0 32.2 116
50.0 21.8 78.5
100.0 24.5 88.1
200.0 14.2 51.3
Sodium Molybdate
Concentration P.E.(%) R.P.E.(%)
G*g/ml)
0.0 26.0 100
1.0 24.1 92.8
10.0 22.5 86.5
100.0 24.5 94.2
500.0 25.1 96.6
Vanadyl Chloride
Concentration P.E.(%) R.P.E.(%)
(H g/ml)
0.0 22.8 100
0.1 25.3 110.7
0.5 25.5 111.8
1.0 20.9 80.3
5.0 0.7 3.3
10.0 0 0
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Aluminium Chloride
Concentration P.E.(%) R.P.E.(% )
( M g / m l )
0.0 15.4 100
1.0 14.4 93.3
10.0 15.8 102.3
100.0 12.4 80.4
500.0 10.5 68.2
Titanium Chloride
Concentration P.E.(%) R.P.E.(%)
(jx g/ml)
0.0 24.1 100
10.0 24.1 100
50.0 18.5 76.8
100.0 16.0 66.4
500.0 4.5 18.7
1 3 9
II. Metal particles
* denotes average of six controls (P.E. range 41.4 - 45.9)
Cobalt Particles
Concentration
(Mg/ml)
P.E.(%) R.P.E.(% )
0.0 43.2 o o *
0.1 25.6 59.2
0.5 10.2 23.7
1.0 1.4 3.2
5.0 0 0
10.0 0 0
Nickel Particles
Concentration
(/xg/ml)
P.E.(%) R.P.E.(% )
0.0 43.2 100 *
5.0 33.6 77.7
10.0 21.1 48.8
50.0 4.75 11.0
100.0 1.1 2.5
Chromium Particles
Concentration 
(fig/ml)
P.E.(%) R.P.E.(% )
0.0 43.2 100 *
5.0 44.4 102.7
10.0 36.4 84.2
50.0 37.5 86.8
100.0 35.6 82.4
500.0 23.0 53.2
1 4 0
Iron Particles
Concentration 
G*g/ml)
P.E.(%) R.P.E.(%)
0.0 43.2 100 *
5.0 40.7 94.3
10.0 41.1 95.1
50.0 39.6 91.6
100.0 42.0 97.2
500.0 25.6 59.2
Molybdenum Particles
Concentration P.E.(%) R.P.E.(% )
(Mg/ml)
0.0 43.2 100 *
5.0 38.4 88.9
10.0 41.2 95.5
50.0 29.2 67.7
100.0 30.0 69.4
500.0 9.1 21.1
Titanium Particles
Concentration P.E.(%) R.P.E.(%)
(Mg/ml)
0.0 43.2 100 *
5.0 38.5 89.1
10.0 34.0 78.7
50.0 25.4 58.8
100.0 18.6 43.1
500.0 8.7 20.2
Vanadium Particles
Concentration P.E.(%) R.P.E.(%)
0*g/ml)
0.0 13.7 100
5.0 11.9 86.4
10.0 9.8 70.9
50.0 1.6 11.8
100.0 0 0
1 4 1
Aluminium Particles 
Concentration
(fig/ml)
P.E,(%) R.P.E.(% )
0.0 43.2 o o *
5 .0 33.7 78.1
10.0 34.7 80.4
50.0 29.0 67.1
100.0 32.5 75.2
500.0 13.2 30.7
Stainless Steel
Concentration P.E.(%) R.P.E.(% )
(fig/ml)
0.0 13.8 100
5.0 11.1 80.6
10.0 10.5 76.0
50.0 4.0 29.0
100.0 2.2 16.3
500.0 0.1 1.0
Cobalt-chromium alloy
Concentration P.E.(%) R.P.E.(% )
(fig/ml)
0.0 43.2 100 *
5.0 42.2 97.8
10.0 41.6 96.3
50.0 39.6 91.6
100.0 30.5 70.6
500.0 21.9 50.7
Ti6A14V Alloy
Concentration P.E.(%) R.P.E.(% )
Oug/ml)
0.0 14.9 100
5.0 13.4 96.9
10.0 7.5 54.3
50.0 3.0 21.7
100.0 1.1 8.1
500.0 0 0
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